Preoperative exercise protocol to aid recovery (PREPARE) in radical cystectomy: a randomized controlled feasibility study by Banerjee, Srijit
Preoperative exercise protocol to aid 
recovery (PREPARE) in radical 
cystectomy: a randomized controlled 
feasibility study 
 
 
 
 
 
     by 
 
 
Mr Srijit Banerjee  
 
 
 
 Doctoral thesis submitted in fulfilment of the requirements for the 
award of Doctor of Medicine (MD) of University of East Anglia 
 
     2016 
  
1 
 
Abstract 
 
Introduction: 
 
Radical cystectomy (RC) and urinary diversion is the gold standard treatment for both 
muscle-invasive urinary bladder cancer and for non-muscle invasive disease refractory 
to intravescical treatment. This is also one of the most complex urological procedures. 
Despite improvements in practice, technique and process of care, RC is still associated 
with significant complications, including death, with wide variability in reported 
postoperative morbidity and mortality rates ranging from 19% to 64% and 0.8% to 
8.3%, respectively.  
 
Cardiopulmonary Exercise Testing (CPET) is a non-invasive measurement of cardio-
pulmonary fitness. CPET variables such as anaerobic threshold (AT) and maximal 
oxygen consumption (VO2 max) have been demonstrated to be reliable predictors of 
postoperative morbidity, mortality and hospital length of stay (LOS) following major 
surgery and are helpful in risk stratifying patients. The foundations of enhanced 
recovery programmes (ERPs), also known as enhanced recovery after surgery or fast-
track surgery, were laid down by Kehlet in the 1990s and have received widespread 
acceptance in various surgical specialities. The principles of these peri-operative 
strategies are to use a multidisciplinary approach to minimising morbidity. This 
revolves around a team approach, which includes surgeons, anaesthetists, nurses, 
physiotherapists, stoma therapists, dieticians and most importantly requires active 
participation from the patient and their family. The role of exercise training or 
‘prehabilitation’ for optimising preoperative physiological function to counter catabolic 
effects of surgery has received little attention in patients undergoing radical cystectomy 
(RC). This randomised controlled feasibility study examines whether a short 
preoperative course of supervised exercise sessions is feasible, well tolerated and 
whether it can lead to an improvement in cardiopulmonary fitness in patients 
undergoing RC. 
 
Methods: 
Over a 2 year period patients awaiting RC were randomised to either a control arm or 
an exercise intervention arm after initial CPET assessment.  Patients in the exercise arm 
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were offered twice weekly supervised exercise sessions preoperatively for 4 weeks, 
whilst the control arm had standard care. Repeat assessment was performed in both 
groups at the end of 4 weeks.  Feasibility outcomes such as recruitment rate, compliance 
and adverse events were recorded. Postoperative recovery including complications 
stratified as per Clavien classification and LOS were also recorded. 
 
Results: 
112 eligible patients were approached of whom 60 were recruited to the study, with a 
recruitment rate of 53.5%. Mean age was 72 years (range 52-85 years). Nine (15%) 
patients did not complete repeat CPET testing.  No adverse events were recorded during 
CPET testing or exercise sessions. Compliance with exercise sessions was satisfactory 
with patients attending for a median of 8 sessions. Dropout rate from the exercise 
sessions in the intervention arm was 23.3% (n=11). An analysis of covariance 
(ANCOVA) showed a statistically significant increase in mean VO2 max in the 
intervention group when compared to the control group by +1.9ml/kg/min (0.87-3, 95% 
CI), (p=0.001). AT was also similarly increased by +0.33ml/kg/min (-0.68-1.3, 95%CI) 
(p=0.5). Mean preoperative VO2 max was found to be significantly higher (p<0.001) in 
patients who had an uncomplicated recovery (22.04ml/kg/min) when compared to those 
with complications (Clavien grade I or above) (16.32ml/kg/min). Analysis using 
Spearman’s rank correlation coefficient demonstrated a negative association between 
day of discharge from hospital and initial VO2 max (p<0.001) indicating quicker 
postoperative recovery in patients with higher cardiorespiratory fitness levels. 
Although not statistically significant there appears to be a trend with complication rates 
being higher in the control group (39.28%) compared to the exercise intervention arm 
(33.3%) (p=0.8) 
 
Conclusion: 
CPET assessment and exercise training is safe and well tolerated. Patients comply with 
a supervised exercise regime and there is a measurable improvement in their 
cardiorespiratory fitness after 4 weeks. The data demonstrates that VO2 max is a reliable 
predictor of outcomes following RC and can potentially be used to risk-stratify patients 
preoperatively. Although the study is not adequately powered to fully investigate the 
results of exercise training on postoperative outcomes, the results are promising, and 
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suggest the requirement for larger randomised controlled trials to elucidate the role of 
prehabilitation prior to surgery in this population.  
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Chapter 1: Introduction 
 
1.1 Bladder cancer epidemiology: 
 
Bladder cancer is the ninth most commonly diagnosed cancer worldwide, with more 
than 380,000 new cases each year and more than 150,000 deaths per year(1).  In 2011, 
there were 10,399 new cases of bladder cancer diagnosed in the UK with 7,452 (72%) 
in men and 2,947 (28%) in women, giving a male: female ratio of around 2.5:1. The 
incidence rate shows that there are 24 new bladder cancer cases for every 100,000 males 
in the UK, and 9 for every 100,000 females(2). 
 
 
1.2 Risk Factors for Bladder Cancer: 
 
1.2.1 Age:  
 
Age is now widely accepted as the greatest single risk factor for developing bladder 
cancer. While bladder cancer can occur at any age, it is generally a disease of middle-
aged and elderly people. With the median age at diagnosis being 70 years, it is rare to 
find bladder cancer in those below the age of 50 years(3,4). 
 
 
1.2.2 Gender: 
 
Bladder cancer is the fourth most common cancer in UK in men after prostate, lung and 
colorectal cancers, accounting for 6.6% of all cancer cases(5). Men are nearly three 
times more likely to develop the disease than women. While men are at higher risk than 
women for developing bladder cancer, women tend to present with more advanced 
disease(3). 
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1.2.3 Tobacco smoking: 
 
Approximately 40% of bladder cancer cases are attributable to cigarette smoking(6). 
Smoking cigarettes increases the relative risk of bladder cancer between 2 to 6 fold, 
depending on the overall duration of smoking and the number of cigarettes  smoked per 
day(7). Cigarette smoke contains the carcinogens 4-aminobiphenyl (4ABP) and 2 
napthylamine. Slow hepatic acetylation (detoxification) of 4ABP by N- 
acetyltransferase and Glutathione S-transferase by induction of the cytochrome P-450 
1 A2 demethylating enzyme appears to increase urothelial carcinogenic exposure (8). 
Smoking also leads to higher mortality rate from bladder cancer during long-term 
follow-up. There is a slow risk reduction (over 20 years) following cessation of 
smoking (9). 
 
1.2.4 Occupational Exposure to chemicals: 
 
Occupational exposure is an important risk factor for bladder cancer.  Historically 
work-related cases accounted for 10% of bladder cancer (10,11). Individuals in 
occupations involving exposure to aniline dyes and aromatic amines such as rubber or 
cable manufacturing had an increased risk of bladder cancer, due to exposure to 
carcinogens commonly encountered in those industries, including  β-napthylamine and 
polycyclic aromatic hydrocarbons (12). There exists a latent period of 25 to 45 years 
between exposure and carcinogenesis (13). 
 
1.2.5 Radiation Therapy: 
 
Recent studies have shown an increase in incidence of bladder cancer in patients who 
have been treated with radiotherapy for other pelvic malignancy such as prostate and 
gynaecological malignancy (14,15). According to several studies external beam 
radiotherapy (EBRT) has been identified as an independent risk factor for secondary 
primary bladder cancer. The latency period between radiotherapy and developing 
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bladder cancer appears to vary between 3.07 years to 5.75 years although some other 
studies have reported a longer latency period of up to 30 years depending on the dose 
of pelvic radiation (16,17). As bladder cancer requires a long time to develop, patients 
treated with radiation at a young age are at highest risk and should be followed up 
closely. 
 
 
1.2.6 Dietary factors: 
 
As bladder cancer is common in the Western world several dietary factors have been 
believed to be related to bladder cancer, however a link remains controversial.  A recent 
meta-analysis reporting  data on bladder cancer and diet supported the hypothesis that 
vegetable and fruit intake reduced the risk of bladder cancer(18). 
 
1.2.7 Chronic urinary tract infection: 
 
 Squamous cell cancer of the bladder is believed to be related to chronic irritation of the 
bladder such as due to chronic infection and long term catheterisation(19). 
 
1.2.8 Bladder schistosomiasis: 
 
Bladder schistosomiasis (bilharziasis or liver fluke) is a common parasitic infection that 
affects sub-Saharan population. This has been established as a common cause for 
bladder cancer affecting people living in these countries. There appears to be a fivefold 
increase in risk in developing bladder cancer in patients who have been chronically 
exposed to this parasitic infection(20,21). 
 
1.3 Diagnosis of bladder cancer 
1.3.1 Symptoms: 
 
The most common presenting symptom (85%) of bladder cancer is haematuria. 
Haematuria may be initial, throughout or terminal in the stream. It may also be 
macroscopic ( visible blood in the urine) or microscopic (non-visible blood in the urine, 
only detected with dipstick or urine microscopy) (22,23). Roughly one third (34%) of 
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patients aged more than 50 years and 10% aged less than 50 years with macroscopic 
haematuria seen in the clinic will be diagnosed with  bladder cancer  (24,25) . 
 
Patients often have non-visible haematuria that was detected during routine screening 
by their general physicians. Less than 5% of those aged less than 50 years and 7-13% 
of those aged more than 50 years will have a urological malignancy in this group 
(26,27). 
 
Some patients can complain of lower urinary tract symptoms such as urgency of 
urination and suprapubic pain along with microscopic or macroscopic haematuria. This 
is often referred to as “ malignant cystitis” (26). 
 
More advanced cases of bladder cancer may present with symptoms of metastatic 
disease. These may include lower limb swelling due to lymphatic or venous obstruction, 
bone pain, weight loss, jaundice (due to liver metastasis) anorexia, confusion and renal 
failure secondary to ureteric obstruction (20). 
 
1.3.2 Cystoscopy: 
 
 
Diagnosis of bladder cancer is ultimately made by a combination of cystoscopy and 
histological evaluation of multiple bladder biopsies. Cystoscopy involves direct 
visualisation of the bladder using a flexible optical instrument called a cystoscope. This 
is often performed as an outpatient or office procedure under local anaesthetic and 
sterile precautions. Bladder cancer is often seen as an area of mucosal abnormality or a 
papillary or solid growth. A careful description of the  cystoscopic findings (such as 
position of the tumour, size, appearance and number ) is necessary  as it helps to guide 
the further management of the cancer and to risk stratify patients (20). 
 
Although conventionally cystoscopy is performed using white light, recently there have 
been advances using blue light/ultraviolet light to detect a greater number of cancers. 
In this procedure before the cystoscopy a chemical (5-aminolaevulinic acid or 
hexaminolaevulinic acid) is instilled in the bladder of the patient via a catheter. 
Cystoscopy subsequently performed using blue light or ultraviolet light then not only 
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picks up the visible tumours, but also lesions in the mucosa which may have been 
missed by white light alone. Although the detection rate is slightly higher using this 
method, it can often lead to false positive results as well as adding extra cost 
implications (28–30). 
 
1.3.3 Urine Cytology: 
 
Examination of voided urine to look for cancer cells (urine cytology) offers a useful 
adjunct to cystoscopy in picking up cancer of the bladder or urinary tract. It works on 
the principle that cancer cells are loosely adherent to the tumour and are often shed in 
the urine. Urine cytology however lacks the specificity of determining the site of the 
cancer (anywhere in the urinary tract starting from the kidneys through the ureters and 
into the bladder). This test also has low sensitivity for low-grade tumours (31–33). Most 
reported sensitivities for low-grade tumours are in the region of 30–60% (34) . However 
the specificity is high for high grade tumours, in the region of 90% (35). Cytological 
interpretation is user dependent. The evaluation can be hampered by low cellular yield, 
urinary tract infections or intravescical installation of BCG. Current guidelines suggest 
using urine cytology as an adjunct to cystoscopy for diagnosis of bladder cancer, but its 
value as a first line test in haematuria clinic is limited (36). 
 
1.3.4 Urinary markers: 
 
Several urinary marker tests have been investigated, regarding their diagnostic accuracy 
and possibility of complementing cystoscopy in the diagnosis of bladder cancer. 
Although several tests and combinations of markers have shown promising 
performance, their diagnostic accuracy cannot be considered sufficient to replace 
cystoscopy(37). Some tests which have been evaluated include fluorescence in situ 
hybridization (FISH), the nuclear matrix protein 22 (NMP22) and Urinary BC antigen 
(UBC) (38). The disadvantage of all these tests is their limitation to a simple positive 
or negative result as well as the fact that they are time-consuming to perform and 
expensive and as such they are unlikely to replace cystoscopy as a diagnostic test.  A 
pooled analysis of predominantly cross-sectional studies yielded a sensitivity of 44% 
for cytology for all types of bladder cancer but higher sensitivity for immuno-cytology 
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(84%), fluorescence in situ hybridization (FISH) (76%), and nuclear matrix protein22 
(NMP22) (68%) (39,40). 
 
 
1.3.5 Imaging: 
 
Bladder masses identified by diagnostic imaging such as ultrasound scan, intravenous 
urography, computed tomography (CT) or magnetic resonance imaging (MRI) should 
be confirmed with cystoscopy and histology. Imaging is much more useful in staging 
of the bladder cancer and identifying any hydronephrosis indicating ureteric 
obstruction. 
 
Detecting extravesical extension of bladder cancer is an important feature of the bladder 
wall evaluation before radical cystectomy, as its presence negatively affects prognosis. 
Contrast-enhanced CT is reasonably accurate at this assessment and peri-vesical fat 
invasion on multi-detector row helical CT (MDCT) has been shown to have sensitivity 
and specificity of 89% and 95%, respectively (41). 
 
Imaging helps to detect evidence of lymph node metastases in bladder cancer. MRI and 
CT diagnoses of positive LN are based on size criteria where nodes > 8 mm or > 10 
mm are considered positive for round and oval nodes, respectively (42,43). Size criteria 
alone lack both sensitivity and specificity, because small metastatic nodes may be 
missed and enlarged benign nodes may be misclassified. 
 
Imaging is also used in bladder cancer to evaluate the response of chemotherapy in 
advanced bladder cancer. A positive early response would provide support for 
continuing with chemotherapy, whereas disease progression would indicate the need 
for a change in therapy such as RC (44). 
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1.3.6 Transurethral Resection (TUR): 
 
Transurethral resection of the tumour is both a diagnostic (as it provides histological 
samples) and therapeutic (as it removes the growth in superficial bladder cancer) tool. 
This is undertaken under general or spinal anaesthesia. The goal of TUR in Ta,T1 BC 
is to make the correct diagnosis and completely remove all visible lesions. It is a crucial 
procedure in the diagnosis and treatment of BC. TURBT should be performed 
systematically in individual steps. According to current EAU guidelines the following 
steps may be considered whilst performing TURBT: 
 perform resection in one piece for small papillary tumours (< 1 cm), including 
a part from the underlying bladder wall. 
  perform resection in fractions including the exophytic part of the tumour, the 
underlying bladder wall with the detrusor muscle, and the edges of the resection 
area for tumours > 1 cm in diameter.  
 take biopsies from abnormal-looking urothelium.  
 biopsies from normal-looking mucosa (trigone, bladder dome, and right, left, 
anterior and posterior bladder walls) are recommended when cytology is 
positive or when high-risk exophytic tumour is expected (non-papillary 
appearance). 
 take biopsy of the prostatic urethra in cases of bladder neck tumour, when 
bladder CIS is present or suspected, when there is positive cytology without 
evidence of tumour in the bladder, or when abnormalities of the prostatic 
urethra are visible. If biopsy is not performed during the initial procedure, it 
should be completed at the time of the second resection. 
The strategy of resection depends on the size of the lesion. Complete and correct TUR 
is essential to achieve a good prognosis. Sometimes separate biopsies or a second 
resection are undertaken for correct staging (45,46). 
1.4 Staging and Grading: 
 
Grading of bladder cancer indicates the aggressiveness of the tumour whereas staging 
denotes the extent of invasion of the cancer into the bladder wall and beyond. The most 
commonly adopted method of classification in staging is the Tumour Node Metastasis 
(TNM) classification. (table 1) (47). 
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Table 1 : TNM classification of bladder cancer 
T: Primary tumour 
TX Primary tumour cannot be assessed 
T0 No evidence of primary tumour 
Ta Non-invasive papillary carcinoma     
Tis Carcinoma in situ: ‘‘flat tumour’’ 
T1 Tumour invades subepithelial connective tissue 
T2 Tumour invades muscle 
T2a: Tumour invades superficial muscle (inner half) 
T2b: Tumour invades deep muscle (outer half) 
T3 Tumour invades perivesical tissue: 
T3a: Microscopically 
T3b: Macroscopically 
T4 Tumour invades any of the following: 
prostate, uterus, vagina, pelvic wall, abdominal wall 
T4a: Tumour invades prostate, uterus, or vagina 
T4b: Tumour invades pelvic wall or abdominal wall 
 
N: Lymph nodes 
NX Regional lymph nodes cannot be assessed 
N0 No regional lymph node metastasis 
N1 Metastasis in a single lymph node  <2 cm in greatest dimension 
N2 Metastasis in a single lymph node >2 cm but not >5 cm in greatest dimension, 
or multiple lymph nodes, none >5 cm in greatest dimension 
N3 Metastasis in a lymph node >5 cm in greatest dimension 
 
 
M: Distant metastasis 
MX Distant metastasis cannot be assessed 
M0 No distant metastasis 
M1 Distant metastasis 
 
Traditionally, bladder carcinomas have been graded according to the World Health 
Organization (WHO) 1973 grading of urothelial papilloma: well differentiated (G1), 
moderately differentiated (G2), or poorly differentiated (G3). In 2004, the WHO and 
the International Society of Urological Pathology (ISUP) published a new grading 
system that employs specific cytological and architectural criteria (48,49). The new 
WHO/ISUP classification differentiates between papillary urothelial neoplasms of low 
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malignant potential (PUNLMP) and low-grade and high-grade urothelial carcinomas. 
(table 2) 
 
 
Table 2: WHO grading of bladder cancer 
WHO 1973 
  Urothelial papilloma 
  Grade 1: well differentiated 
  Grade 2: moderately differentiated 
  Grade 3: poorly differentiated 
 
WHO 2004 
 
 Urothelial papilloma 
 PUNLMP (papillary urothelial neoplasms of low malignant potential) 
 Low-grade papillary urothelial carcinoma 
 High-grade papillary urothelial carcinoma  
 
 
 
 
 
1.5 Treatment of bladder cancer: 
 
Bladder cancer is a heterogeneous disease, with 70% of patients presenting with non -
muscle invasive (NMI or superficial tumours), which tend to recur but are generally not 
life threatening, and 30% presenting as muscle-invasive disease (MIBC) associated 
with a high risk of death from distant metastases (20). 
 
1.5.1 Treatment of non-muscle invasive (NMI) bladder cancer: 
 
The initial treatment for superficial (stages Ta, T1, or tumours in situ [Tis]), bladder 
cancer is transurethral resection of the bladder tumour. This resection should include 
muscularis propria, especially if the lamina propria is affected or the tumour is high 
grade. When the transurethral resection shows lamina propria invasion a repeat 
resection should be performed to rule out muscularis propria invasion. Moreover, the 
tumour is often under staged by initial resection. The likelihood that muscle-invasive 
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disease is detected by second resection of initially T1 tumour ranges from 4-25%, and 
it increases to 45% if there was no muscle in the initial resection (50). 
 
50–70% of these NMI tumours will recur and approximately 10–20% will progress to 
muscularis propria invasive disease (T2–4) (51). The high rate of recurrence is the 
feature of bladder cancer that makes follow-up a crucial component in effective 
management. After transurethral resection of the tumour, patients should have 
cystoscopic follow up that needs to be tailored to the stage and grade of the tumour. To 
facilitate treatment recommendations, it is important to categorise patients into risk 
groups. Based on available prognostic factors and in particular data from the EORTC 
risk tables, the EAU Guidelines panel recommends stratification of patients into three 
risk groups for superficial bladder cancer i.e. low, intermediate and high risk (table 3) 
(52). 
  
Table 3 :Risk stratification of superficial BC 
Risk group stratification Characteristics 
Low-risk tumours primary, solitary, Ta, G1 (PUNLMP, 
LG), < 3 cm, no CIS 
Intermediate-risk tumours All tumours not defined in the two 
adjacent categories (between the 
category of low- and high-risk) 
High-risk tumours Any of the following:  
•T1 tumour 
 •G3 (HG) tumour  
•CIS  
•Multiple and recurrent and large 
(>3cm) Ta G1G2 tumours (all 
conditions must be presented in this 
point) 
 
Upper tract imaging should be done, in selected patients, every 12–24 months to 
establish whether a transitional cell carcinoma is present in the renal collecting system 
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or ureters, because lifetime risk for the development of this upper tract tumour after a 
diagnosis of bladder cancer is about 5% (23). 
 
Agents used for intravesical therapy are the immunomodulators such as BCG and 
interferon alpha, and chemo therapeutic agents such as mitomycin, doxorubicin, 
thiotepa and gemcitabine. Immediately after transurethral resection, one dose of 
intravesical chemotherapeutic agent is effective for the reduction of disease recurrence 
within the first 1–5 years after resection, the commonly used agent being mitomycin 
(46). Patients with high risk disease (multifocal Tis, high grade Ta or T1 tumours with 
associated Tis, and tumours that rapidly recur after transurethral tumour resection) 
should be regarded as candidates for further adjuvant courses of intravesical drug 
therapy. Such regimens generally consist of an induction course of BCG once every 
week for 6 weeks, and then, usually, intermittent maintenance cycles of one installation 
every week for 3 weeks. This 3-week course is repeated every 4–6 months for up to 2 
years.(46,53). In the trials with BCG maintenance, there was a 32% reduction in the 
risk of recurrence. Two meta-analyses have demonstrated that BCG therapy prevents, 
or at least delays, the risk of tumour progression (54,55). 
 
1.5.2 Treatment of muscle invasive bladder cancer with 
cystectomy: 
 
The standard treatment for bladder cancer invading the muscularis propria (either at 
presentation or when the disease progresses in spite of intravescical chemotherapy) is 
radical cystoprostatectomy for men and anterior exenteration including the bladder, 
urethra, uterus, and ventral vaginal wall for women. In men, a urethrectomy should be 
done when invasion of the prostatic stroma or concomitant Tis in the urethra is evident. 
After radical cystectomy, urinary diversion is performed in either a non-continent or 
continent fashion, using a segment of bowel. The simplest form is the non-continent 
ileal conduit. A continent urinary diversion can be either an orthotopic neobladder or 
an abdominal pouch. In both diversions a segment of bowel is made into a detubularised 
spherical form, with continence in the abdominal pouch relying on a catheterisable 
continent stoma and on the patient’s striated urethral sphincter in the orthotopic 
neobladder (1,23). 
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1.6 Radical cystectomy; morbidity and mortality: 
 
Radical cystectomy (RC) and urinary diversion is the gold standard treatment for 
muscle-invasive urinary bladder cancer as well as for non-muscle invasive disease that 
is refractory to intravesical treatment. This is also amongst the most extensive 
urological surgical procedures. Despite improvements in practice, technique and 
process of care, RC is still associated with significant complications, including death, 
with wide variability in reported postoperative morbidity and mortality rates ranging 
from 19% to 64% and 0.8% to 8.3%, respectively (56,57). 
 
Kim et al in a recent series with a cohort of 50 ,625 patients who underwent RC found 
that the overall complication and mortality rates were 28.8% (14 584) and 2.1% (1081), 
respectively after surgery(58). The authors investigated the common causes of 
morbidity in this cohort and found 17% of the patients had postoperative digestive or 
bowel related complications (such as ileus, bowel injury and anastomotic leak etc.), 
while 4% had postoperative infections (including chest infection), 4% had cardiac 
complications, and 4% had wound complications. Although lower morbidity and 
(perioperative) mortality have been observed by surgeons and in hospitals with a higher 
caseload and therefore more experience, it still remains significantly high (59,60). 
 
RC has come a long way since it was originally described in 1949 by Marshall and 
Whitmore who described the basic surgical principles of radical cystoprostatectomy 
(61). In 1987, following the neuroanatomic mapping of the pelvic plexus by Schlegel 
and Walsh, nerve-sparing cystectomy became a surgical option that allowed for 
preservation of sexual function. Over the years it has become evident that surgical 
approach (ie, open vs minimal access) does influence outcomes, complications and 
recovery rates. Minimally invasive surgery requires smaller incisions, reduces 
analgesic use, reduces bowel handling, and decreases blood loss (62). As such, 
laparoscopic RC may decrease postoperative complications, pain, and LOS compared 
with open surgery. However, it is unclear whether laparoscopic resection provides 
better outcomes than open surgeries (63). Robot-assisted surgical approaches are 
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increasingly utilized in urology but the exact benefit over open surgery remains unclear 
(63). Limited evidence suggests similarities in oncology and morbidity, with reduced 
blood loss and analgesic use, although operating times are significantly longer (64,65). 
Procedure-specific RCTs that incorporate cost analysis, recovery rates, and quality of 
life (QoL) outcomes are needed to assess the advantages of robotic assisted 
laparoscopy.  
 
While the variability of peri-operative mortality may be explained by several factors, 
including patient characteristics (age and baseline medical conditions) disease 
characteristics (nodal involvement and lymphovascular invasion) and surgical 
technique (that is open or minimally invasive and conduit or orthotopic neobladder 
formation) the quality of postoperative care is equally important. In this respect, 
recognition of adverse events and a prompt management of these complications 
influence peri-operative mortality (66). ‘Failure to rescue’ is a term often coined for 
this patient group who died after a treatable post-operative complication (67). It is 
hypothesized that the ability of a hospital to successfully treat (rescue) a patient who 
suffers a complication is strongly related to the quality of care provided,  whereas the 
occurrence of the complication is more closely related to the patient’s underlying risk 
(68).  
 
 
1.7 Enhanced recovery and its role in radical cystectomy: 
 
The foundations of enhanced recovery programmes (ERPs), also known as enhanced 
recovery after surgery or fast-track surgery, were laid down by Kehlet in the 1990s (69). 
The principles of these peri-operative strategies are to use a multidisciplinary approach 
to minimising morbidity. This revolves around a team approach, which includes 
surgeons, anaesthetists, nurses, physiotherapists, stoma therapists, dieticians and, most 
importantly, requires active participation from the patient and family (70). They 
minimize physiological stress caused by surgery and promote recovery. Significant 
reductions in hospital stay have been shown without increased complications or 
readmissions (71,72). ERPs decrease ileus, prevent loss of lean body mass, reduce 
atelectasis, promote oxygenation and preserve cardiovascular response to exercise after 
surgery. ERPs have spread from colorectal surgery to other surgical specialities. Much 
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of the data from ERPs are from colorectal surgery however there is an increasing 
number of publications in the urological literature from UK centres describing this 
experience and adding on to an ever increasing evidence base (73,74). 
 
Components of a typical ERP in Radical cystectomy as per McGrath et al are as follows: 
(75) 
 
 Pre-assessment is used to inform participants, to highlight and overcome 
psychosocial barriers to early recovery or discharge, and to trigger medical 
optimization if required. Involvement of stoma nurses and oncology nurses to 
prepare patients for urostomy bags is crucial at this stage. 
 
 Admission on the day of surgery and continuing clear fluids till up to 4 hours 
before surgery. Some centres prefer carbohydrate loading for a few days 
leading up to surgery. Traditional bowel preparation has been shown to confer 
no advantage in patients undergoing RC (76). 
.  
 Prevention of intraoperative hypothermia by careful temperature monitoring, 
use of “bear huggers” and warmed fluid infusion. This reduces sympathetic 
responses, cardiac arrhythmias and wound morbidity. 
 
  High inspired oxygen level during the perioperative period increases intestinal 
oxygenation, reduces wound infection, and decreases postoperative nausea and 
vomiting.  
 
 Goal-directed fluid therapy with oesophageal doppler allows precise fluid 
balance, and this reduces surgical complications and shortens length of hospital 
stay(77). 
 
 Optimized pain relief allows early mobilization and opiate-sparing analgesia 
reduces nausea, vomiting and sedation. Epidural analgesia, is an important 
component of ERPs.  
 
 Traditional management after surgery has involved resting the gastrointestinal 
tract until it regains its function. However, studies have confirmed the safety of 
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early postoperative feeding in elective colorectal surgery and such findings 
have been reported in patients undergoing RC.  
 
 Early mobilisation and early feeding are also an important part of ERP. 
 
 Minimally invasive surgery, such as laparoscopic and robotic assisted RC, 
where feasible is also helpful in enhancing recovery. 
 
 
 
Patients undergoing radical cystectomy are a particularly applicable group for ERPs, as 
the procedure is still associated with significant morbidity and a prolonged inpatient 
stay by comparison with other operations. Implementation of an ERP for radical 
cystectomy in one UK centre reduced postoperative stay by 3 days, with no effect on 
morbidity or mortality (78). 
 
The major focus of the ERP literature to date has been on peri and post-operative care. 
Improving the outcome for these participants, however, could begin long before the 
participant arrives at the preoperative assessment visit. A surgical procedure such as 
radical cystectomy is associated with a catabolic state, similar to prolonged endurance 
exercise and as such it is plausible that the outcome from surgery is more likely to be 
favourable if the patient has been “pre-conditioned” to undergo the stress of surgery.  
 
1.8 Preoperative fitness as an independent predictor of outcome 
in Radical Cystectomy (RC): 
 
Clinicians often risk stratify patients before major surgery based on their age, weight 
and comorbidities to attempt to predict their post-operative morbidity and mortality. 
Methods (such as ASA grading) although commonly used have its limitations including 
largely being a subjective  assessment of the patient's fitness for surgery(79). 
Cardiopulmonary exercise testing (CPET) is a clinical tool used to objectively measure 
the performance of the cardiorespiratory system and assess an individual’s functional 
capacity (fitness level). CPET is a graded exercise challenge which, through non-
invasive measurements of gas exchange through analysis of exhaled air, ECG trace 
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observation, and analysis of heart rate, blood pressure, and peripheral oxygen 
saturation, allows the cardiovascular and respiratory systems to be studied under the 
controlled ‘stress’ of exercise (80). Although alternative methods of assessment of 
cardiorespiratory fitness such as 6 min walk, shuttle walking and stair climbing have 
been proposed, CPET provides the most objective assessment of fitness(80,81). 
Various CPET assessment parameters are commonly used, including VO2 max (VO2 
max), AT (anaerobic threshold), VE/ V02 and VE/VCo2  (ventilatory equivalent of oxygen 
and carbon dioxide respectively).  
 
 Almost two decades ago, Older and colleagues identified an association between low 
functional capacity determined by CPET, and poor patient outcome following non-
cardiopulmonary surgery (82). In their study they demonstrated that a low AT was 
associated with an increased mortality rate in elderly patients following surgery. In 
general, patients with an AT <11 ml/kg/min had a higher rate of cardiovascular 
mortality (18%) than those with an AT >11 ml/kg/min (0.8% p <0.001) (83).  Assessing 
843 patients undergoing major colorectal surgery, radical nephrectomy and cystectomy, 
Wilson et al. concluded that in this patient cohort (aged >55 years), an AT of 11 ml 
/kg/min or less and a VE/VCO2 of 34 or more had a sensitivity of 88% and a specificity 
of 47% for hospital mortality (84). Based on this, and subsequent published literature, 
CPET-derived variables have been increasingly adopted as objective measures of 
fitness prior to surgery, particularly within the National Health Service (NHS) in the 
UK. This information is used to inform operative decisions, choice of perioperative 
management and to discuss risk with patients (85). In a recent literature review, in data 
spanning 2275 patients over 12 studies, Grocott et al demonstrated that CPET variables 
are reliably associated with outcome measures such as LOS and morbidity and 
mortality following major surgery. CPET also has utility in identifying the high-risk 
surgical patient. However, the optimal predictor of high risk appears to differ between 
surgery types, with AT shown to be the best indicator of higher risk patients for major 
intra-abdominal surgery  and  VO2 max  associated with outcome following  upper GI 
surgery (80). 
 
Radical cystectomy (RC) with pelvic lymph node dissection and ileal conduit or 
orthotopic bladder reconstruction remains the ‘gold standard’ surgical treatment for 
muscle-invasive bladder cancer (86). However, RC is associated with high rates of 
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morbidity (19–64%) and mortality (0.8-8.3%) (87–91). The average length of stay 
across the UK after radical cystectomy is 14-17 days (92). A recent study of 82 patients 
undergoing radical cystectomy for bladder cancer demonstrated impaired preoperative 
cardiopulmonary reserve was related to major morbidity, prolonged LOS (length of 
stay) and increased use of critical care resource after RC(93). They concluded that 
anaerobic threshold (AT) remained as the only significant independent predictor 
variable for the presence or absence of major postoperative complications (odds ratio 
0.74, 95% CI 0.57–0.97; P = 0.03). When the optimal predictive value of AT of 12 
mL/min/kg was used as a fitness marker, there was a significant relationship between 
fitness and LOS (median LOS: ‘unfit’ 22 days vs ‘fit’ 16 days; HR 0.47, 95% CI 0.28–
0.80; p= 0.006). 
 
Based on these studies it appears that CPET variables can help to risk stratify patients 
undergoing radical cystectomy. Preoperative recognition of patients with a reduced 
preoperative AT, would firstly warn clinicians of the need to be vigilant in a high-risk 
population. Secondly, it would improve rationalisation of limited critical care resources 
and allow the institution appropriate postoperative care pathways to promote expedient 
recognition and treatment of complications when they occur, conforming to the ‘failure 
to rescue’ principle. It is also plausible that preoperative exercise could improve CPET 
variables in this group of patients. 
 
1.9 Role of ‘Prehabilation’ in the context of radical cystectomy: 
 
 
Interventions to improve post-surgical recovery have usually been intra and 
postoperative, which for high-risk populations might be too late (94). The preoperative 
period might be a better time to engage patients in enhancing physical ﬁtness, that is 
often referred as , ‘prehabilitation’ (95,96). Pre-surgical exercise interventions are 
feasible, safe, improve function, and quality of life, but little is known of their effects 
on physical ﬁtness measured by cardiopulmonary exercise testing (CPET) (97,98). 
Identifying prehabilitation programmes to optimize preoperative ﬁtness is therefore a 
priority. O’Doherty et al in their systematic review of 10 studies analysed the role of 
‘prehabilitation’. They commented based on their review that although there is a lot of 
variations in the type of exercise prescribed in the preoperative period, preoperative 
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aerobic exercise training seems to be generally effective in improving physical fitness 
in patients awaiting intra-cavity surgery and appear to be feasible and safe (98).There 
does not appear to be any consensus however on the optimal duration and intensity or 
the type of exercise that should be prescribed as part of ‘prehabilitation’. It appears 
plausible that benign conditions merit longer duration of preoperative optimisation 
where as in malignant conditions a balance has to be struck between the benefits of 
preoperative exercise versus the risk of cancer progression. A period of 4-6 weeks 
appears to be effective and safe based on several studies (99–101). 
 
Till date there is no evidence on the role of prehabilitation or preoperative exercise in 
patients undergoing RC. 
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Chapter 2: Methods and study design  
 
2.1 Aims of the study  
 
PrEPARe (Preoperative Exercise Protocol to Aid Recovery) for Radical Cystectomy 
was a feasibility study to explore the role of preoperative fitness, as determined by 
CPET, in contributing to an enhanced recovery following radical cystectomy. The aims 
of the study were: 
 
 To explore the feasibility outcomes to form the basis of a larger RCT. The 
principal aim was to look at recruitment rate, reasons for non-recruitment, 
attrition and dropout rates. It was also designed to see if patients who agreed to 
participate would tolerate and comply with a preoperative programme of 
aerobic exercise interval training before cystectomy. 
   
 A secondary aim was to explore any possible improvement in exercise tolerance 
and cardio-respiratory fitness after a short period of aerobic exercise regimen 
before major cancer surgery in an elderly group of people. 
 
 Preliminary data were collected to explore any possible trends in enhancing 
recovery and improving post-operative outcome measures after RC as a result 
of preoperative exercise. This would help in sample size calculations for a future 
large scale definitive RCT. 
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2.2 Study Protocol  
 
 Ethics approval was obtained from the East of England regional ethics 
committee (ref no.11/EE/0127). 
 
 Following ethics approval 60 patients were recruited to this study. Patients who 
had been listed for radical cystectomy (RC) for bladder cancer from the urology 
specialist multidisciplinary team meeting at the Norfolk and Norwich 
University Hospital, were identified as prospective participants. As this was a 
feasibility study there was no formal sample size calculation but we aimed to 
recruit 60 patients (30 in each group), in accordance with recommendations for 
feasibility studies as laid down by COSORT (102,103). 
 
 After the patients had their initial consultation with their respective consultant 
urologist and were made aware of the decision to offer them radical cystectomy, 
they were approached by the chief investigator (SB) and were informed about 
the study. They were supplied with the patient information sheet and 
participants were given at least 24 hours to think about the information supplied 
and clarify any doubts before they decided whether or not they wanted to 
participate in the study. If they declined to take part the reason for 
nonparticipation was also ascertained. 
 
 Once they agreed the participants underwent a baseline CPET assessment. The 
participants were then subsequently randomised to receive either a four week 
intensive exercise training according to a preset exercise protocol (exercise arm) 
or the standard treatment (control arm). 
 
 Randomisation was carried out using a pre-generated sequence, generated 
using N-Query software, (30 patients in each arm) which was kept with a 
secretary who was not part of the trial (to ensure blinding). After initial 
assessment she was informed of the participants’ initials and sequence and 
group allocation were obtained. When participants were approached for 
recruitment it was made clear to them that the role of the study (PREPARE for 
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cystectomy) was to investigate the possible relationship between preoperative 
fitness and post- operative outcome and also the ability to improve fitness in a 
short time span in patients due to undergo major surgery. It was also made clear 
that, as far as the investigators were aware, trial participants would not be 
knowingly advantaged or disadvantaged in anyway by either being in the 
control or exercise arm. 
 
  At the completion of the four week period participants from both group 
underwent further CPET assessment to assess whether there were any 
differences in the CPET parameters. The participants then subsequently 
underwent radical cystectomy as treatment for their bladder cancer. 
 
 Post operatively these patients were monitored and their post-operative course 
charted, including time of discharge from HDU, need for inotropic support, time 
to opening bowel, tolerating diet, mobilising and length of stay in hospital 
(LOS). The complications in the post-operative period were recorded according 
to the Clavien classification. 
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2.2.1 Flow chart of the study protocol  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Study protocol 
  
Recruitment of patients undergoing cystectomy 
 
Baseline CPET assessment 
Randomisation 
 
Control arm  
(No preoperative exercise) 
 
Exercise Arm 
(Regular preoperative exercise) 
Repeat CPET assessment after 4 weeks (Primary end point) 
 
Participants undergo Radical Cystectomy  
(Post-operative outcome measures recorded) 
 
Discharge from hospital  
(Secondary endpoint) 
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2.2.2 Exercise protocol  
 
Participants who were randomised to the exercise arm were invited to attend an exercise 
physiology laboratory at the University of East Anglia for supervised exercise sessions 
comprising 60 min of aerobic exercise based on their background fitness level as 
determined by the CPET analysis (intensity of 70-80% of maximum heart rate achieved 
in the incremental cycle ergometry test). They were invited for these sessions twice a 
week for four weeks. 
 
A typical exercise session would consist of the following 
Warm Up:  
A typical warmup of 5-10 min comprised of freehand exercise of patients’ choice such 
as jogging at one place / paced walking in the exercise physiology lab.  
 
Cycle ergometry exercise:  
Sessions comprised aerobic exercise interval training on a cycle ergometer (Monark 
824E; Varberg, Sweden). This is a static cycle/ bike where the intensity/effort of cycling 
is increased by sequential adding of weights to the flywheel in batches of 500gms.  The 
aim was 6 x 5 min intervals at 70-80% of maximum heart rate (achieved in the 
incremental cycle ergometry test or CPET). Each interval was followed by a 2.5 min 
rest period. A typical exercise session lasted for an hour. Following a 5-10 minute 
warm-up against low resistance, patients performed 6 x 5 min intervals at a target 
perceived exertion of 13-15 (‘somewhat hard’ to ‘hard’), with 2.5 min interpolated rest 
periods. They were instructed to maintain a steady pedalling cadence (pedal rate) of 50-
60 rev/min on the exercise bike during the aerobic intervals and the exercise programme 
was progressed by gradually adding more load to the flywheel to maintain the target 
perceived exertion. 
 
 Heart rate and ratings of perceived exertion according to Borg RPE scale (fig.2), were 
recorded in the final minute of each interval. Rate of perceived exertion or RPE is a 
simple measure, or scale denoting exercise intensity or physical strain (104). The RPE 
functions as a perceptual range from extremely light exercise to extremely hard 
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exercise. The scale numbers from 6 to 20 and often corresponds to a heart rate of 60 to 
200 beats per minute. Descriptors are given to feelings of intensity at each number (very 
light, somewhat hard, hard, very hard, etc.). Exercise intensity was progressed at an 
appropriate rate for each individual’s level of exertion.  
 
Cool Down:  A typical cool down period of 5-10 min was allowed after the cycling 
exercise. Patients were instructed to gradually slow down their pedaling rate till 
complete stoppage. 
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Figure 2: Borg RPE scale 
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Figure 3: Patient undergoing CPET 
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Figure 4: participants during a typical exercise session 
 
 
Standard care and control group:  
The participants who were randomised to the control group were advised to carry on 
with their lifestyles in the “usual” way. They were neither encouraged nor discouraged 
to take on self-directed exercise, however if any participant in the control group did 
undertake any physical exercise (which was not routine for them) then that was 
recorded. 
 
Post –operatively after cystectomy, participants from both the exercise and control 
group had same levels of care which included planned admission to the same HDU for 
the immediate post-operative period and step down ward, patients were looked after by 
the same group of nurses and doctors who would have been otherwise involved in their 
care. The doctors and nurses looking after the participants were blinded to their group 
allocation. 
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2.2.3 Exclusion and inclusion criteria 
 
The patients eligible for the study were identified from the uro-oncology 
multidisciplinary meeting at the Norfolk and Norwich University Hospital NHS 
Foundation Trust. This hospital is a tertiary referral centre in the East of England and 
has a wide catchment area including local district general hospitals namely James Paget 
Hospital, Queen Elizabeth  Hospital, Ipswich Hospital and West Suffolk hospital. The 
Norfolk and Norwich University hospital covers an estimated total population of 1.2 
million people. 
 
Inclusion criteria: 
 
 Those patients who were listed for radical cystectomy for treatment of bladder 
cancer were eligible for recruitment to the study. The decision whether or not 
to offer radical cystectomy to a patient after staging investigations for bladder 
cancer were completed, was taken at the weekly multidisciplinary meeting in 
the urology department at the Norfolk and Norwich Hospital. Usually radical 
cystectomy is offered to patients who have organ confined muscle invasive 
bladder cancer or high risk non muscle invasive bladder cancer (HRNMIBC) 
refractory to intravescical treatment and are fit for the intervention. 
 
 Patients who underwent neo-adjuvant chemotherapy before radical cystectomy 
were also eligible for the study. Patients who underwent neo-adjuvant 
chemotherapy only entered the trial at least two weeks after completion of their 
chemotherapy regimen. 
 
 Patients are often offered different surgical approaches such as laparoscopic or 
open cystectomy as well as different methods of urinary diversion such as 
standard ileal conduit formation or orthotopic neobladder formation. Patients’ 
eligibility to participate in this trial was not limited by the choice of surgery that 
they were offered. 
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Exclusion Criteria: 
 
 Patients who were offered urinary diversion (such as standard ideal conduit) 
for benign disease (such as interstitial cystitis or painful bladder syndrome) 
were excluded from the study. 
 
2.3 Outcome measures recorded 
 
2.3.1 Feasibility parameters: 
 
The main aim of this study was to assess feasibility of preoperative exercise training in 
patients undergoing radical cystectomy for bladder cancer. As such feasibility 
parameters such as recruitment rate and factors influencing recruitment, willingness to 
be randomised, and adherence of the participants in terms of exercise protocol, adverse 
events during CPET assessment or during exercise sessions and attrition during the trial 
were recorded. This would help to inform the design of a future RCT with the aim of 
exploring the role of preoperative exercise in enhancing recovery after radical 
cystectomy. 
 
 
2.3.2 Preoperative outcome measures:  
 
CPET assessment  
 
CPET is a graded exercise challenge which, through non-invasive measurements of gas 
exchange at the mouth, ECG trace observation, and analysis of heart rate, blood 
pressure, and peripheral oxygen saturation, allows the cardiovascular and respiratory 
systems to be studied under the controlled ‘stress’ of exercise. This allows inspection 
of the integrated oxygen delivery system when the demand for oxygen is high and the 
system is required to function near to its maximum capacity. Despite requiring a 
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moderate to high level of exertion, CPET is well tolerated by patients and is safe to 
conduct on most patient cohorts (80). 
 
Before the start of CPET assessment a detailed medical history of the patient was 
obtained. Height, weight and resting blood pressure were also recorded.  
 
CPET was conducted on an electronically-braked cycle ergometer (Excalibur Sport, 
Lode ® Netherlands). Initial rest phase (approximately 2 min) was employed to 
establish baseline values, followed by an unloaded cycling (0 W) phase to allow the 
patient to become familiar with the cycling motion and to reduce the influence of the 
lag present between increased work rate (WR) and the oxygen uptake (VO2) response. 
Following this, the incremental exercise phase began. A ramp protocol (20 watt /min, 
unless the patient was very unfit in which case a slightly lower intensity of 10 watts 
/min) was used, during which the set WR was increased linearly with time, with a 
corresponding increase in the intensity of the exercise. Participants were encouraged to 
continue cycling (at least at 50 rev/min speed) to volitional exhaustion or until a plateau 
in oxygen consumption was observed. Heart rate and 12 lead ECG were recorded 
continuously by electrocardiogram (Cardioperfect ®, Welch Allyn USA) and perceived 
exertion (Borg RPE Scale) were assessed at 2 min intervals. 
 
 Upon test completion, a recovery period of low intensity exercise was performed to 
encourage maintenance of venous return, thus reducing the risk of brisk blood pressure 
reduction and associated light-headedness. The patient was observed throughout 
recovery until physiological variables, including heart rate, blood pressure, ventilation, 
and oxygen saturation, were close to baseline levels and any exercise induced ECG 
changes had resolved. All CPET assessments were carried out under medical 
supervision with at least two staff members being present in the exercise physiology 
lab at all times till the completion of the test. Protocol dictated that the test should be 
stopped if the patient experienced any adverse symptoms (e.g. chest pain, dizziness, or 
severe breathlessness) or if the physiological data indicated a potential adverse event 
(e.g. ECG abnormalities, substantial blood pressure changes). A complete list of 
contraindications is listed in the protocol ( appendix 2) 
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Initially the following parameters were measured both in the control and exercise 
(intervention) arm at the physiology lab.  
 
 Maximal oxygen consumption (VO2 max)  
 Minute ventilation  
 Anaerobic threshold  
 VO2 / power slope  
 O2 pulse 
 
After the 4-week intervention these parameters were calculated again to assess if there 
had been any change. The control arm also underwent a similar test at the end of the 4-
week period to control for order or practice effect. A detailed description of these 
parameters measured is as follows:  
 
Maximal oxygen consumption (VO2 max) / peak VO2 
 
VO2 max or peak VO2 (maximal oxygen consumption or aerobic capacity) is the 
maximum capacity of an individual's body to transport and use oxygen during 
incremental exercise, which reflects the physical fitness of the individual (105). 
Accurately measuring VO2 max involves a physical effort sufficient in duration and 
intensity to fully tax the aerobic energy system. In general, clinical and athletic testing, 
this usually involves a graded exercise test (either on a treadmill or on a cycle 
ergometer) in which exercise intensity is progressively increased while measuring 
ventilation and oxygen and carbon dioxide concentration of the inhaled and exhaled air. 
VO2 max is reached when oxygen consumption remains at steady state despite an 
increase in workload (106,107).  
 
Maximum Oxygen uptake (VO2 max), reflecting the upper limit of the body's aerobic 
functioning, is the most widely used parameter characterizing the effective integration 
of the central nervous, cardiopulmonary, and metabolic systems. Its quantification 
(typically by using a cycle ergometer or treadmill) requires oxygen uptake (VO2) to 
reach a value such that further increases in work rate result in no further (or trivially 
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small) increases in VO2 (i.e., a “plateau” is attained). Such a VO2 plateau has been 
viewed as the best criterion for establishing VO2 max. Although in elite athletes VO2 
max is attainable in the non-trained common subjects (which would include elderly 
cancer sufferers) often a “system-limited” peak oxygen uptake (peak VO2) value, rather 
than a VO2 max, is reported.  
 
However, the advent of continuous work rate tests, where the work rate is increased 
every 1 to 3 min (which is the method of determining peak VO2 in the current study), 
largely replaced the progressive, constant-load format (108). Concern had been 
expressed whether the VO2 max attained from these tests was as high as those from the 
“traditional” discontinuous protocol. However, a number of groups found no difference 
in VO2 max between incremental (i.e., progressively increasing work rate every 2 min) 
and discontinuous (where discrete square waves of different work rates are separated 
by periods of rest) constant work rate treadmill tests (109,110). Available evidence 
suggests that “end-exercise” plateaus in VO2 may only be evident in as little as ∼50% 
of the incremental treadmill tests (110,111). In the published literature often the values 
of Peak VO2 and VO2 max are used interchangeably as evidence has pointed out that 
provided the subject has given maximal effort these two values are often same (112). 
We have used the term Peak VO2 and VO2 max interchangeably  to indicate maximal 
oxygen consumption at steady maximal work rate. 
 
Minute ventilation  
 
Minute ventilation (respiratory minute volume, or flow of gas) is the volume of air 
inhaled (inhaled minute volume) or exhaled (exhaled minute volume) from a person's 
lungs in one minute. Minute volume is calculated by taking the tidal volume (volume 
of air per breath) and multiplying it by the respiratory rate (the number of breaths per 
minute). The higher the minute volume the more carbon dioxide (CO2) the person is 
releasing. It is an important parameter the anesthetists’ measure while the patients are 
on ventilator either during or after surgery (113). 
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 Anaerobic threshold (AT):  
 
AT is the point above which the muscles derive their energy mainly from anaerobic 
rather than aerobic sources during exercise. The body can only operate above this 
threshold for a short period of time, such as when sprinting, before lactic acid builds up 
in the muscles.(114) When performing graded exercise, the anaerobic threshold (AT) 
is an estimate of the onset of metabolic acidosis due to an oxygen supply: demand 
imbalance. Numerically it is presented as the rate of oxygen consumption (VO2) at 
which lactic acid starts to accumulate. This is seldom invasively measured but is usually 
taken as the time at which the patient starts to exhale increasing amounts of carbon 
dioxide to compensate for a buildup of lactic acid and resulting metabolic acidosis. The 
AT occurs at about 50–60% of VO2 max in normal individuals but has a range of 30–
80%. It is a well-defined physiological point that can be measured in most patients. A 
low pre-operative AT has been shown to correlate with postoperative mortality (115). 
Although there is no clear agreement on the best single predictor of outcome, thresholds 
of peak oxygen consumption (VO2 peak /VO2 max) of 15 ml /kg/min and an oxygen 
consumption at the anaerobic threshold (AT) of 11 ml/kg/ min have been shown to 
discriminate between higher and lower risk patients in non-cardiac surgery (80). There 
are different methods of calculating AT ,we used the Wasserman method (116). This 
was derived using the ventilatory slope (and is characterized by a disproportionate 
increase in VE/VO2 without an increase in VE/VCO2 values. 2 independent assessors 
(JS and GC) looked at individual gas exchange data to arrive at a consensus value for 
AT for each participant.  
 
 
 
 
Oxygen pulse:  
 
This parameter approximately equates to stroke volume and may reflect   cardiovascular 
disease or ventilator constraint. It is measured as VO2 /Heart Rate. 
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VO2 / power slope: 
 
This represents the relationship between oxygen uptake and work rate (in watts). It is 
reduced in any condition that reduces blood flow to the periphery and is not affected by 
obesity. 
 
2.3.3 Post-operative outcome measures:  
Time spent in HDU  
 
Initially after cystectomy all patients in our unit are transferred to the high dependency 
unit (HDU) for the first post–operative night. This is done to facilitate one-to-one 
monitoring of the patient and pick up any early signs of deterioration. Once the patient 
has stabilised he or she is returned to the general ward. Time spent in HDU is a good 
indicator of initial post-operative recovery (117,118). 
 
Need for inotropic support  
 
Some patients after cystectomy need inotropic support to maintain their blood pressure, 
common examples being noradrenaline and epinephrine. Very often the amount of 
inotropic support  needed, if at all, depends on the physiological reserve to withstand 
major surgical intervention and the amount of blood loss (119,120).  
 
Chest infection and post-operative ileus: 
 
Chest infection and post-operative ileus are the two most common post-operative 
complications after cystectomy and any other major abdomino-pelvic surgery  
(121,122). The presence or absence of these complications, often dictate the length of 
post-operative stay in the hospital. We recorded prospectively if the patients had any of 
these post -operative complications.   
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Clavien –Dindo complications: 
 
Classification of post-operative surgical complications can be challenging. Any 
deviation from the normal post-operative recovery is regarded as a complication.  
Clavien et al first published a system in which complications were systematically 
graded, and that is the basis of the Clavien system (123). In 2004, Dindo et al 
reevaluated and modified their own criteria to increase its accuracy and applicability in 
the surgical community (124). This method of classification of surgical complications 
has been widely accepted and validated in the domain of urological surgery(125–127). 
Several authors while reporting their respective series of experience with radical 
cystectomy have used this method to list their complications (128–130). A brief 
description of this method of classification is given in the table (table 4) below. In the 
current cohort of participants any such deviation from usual post-operative recovery 
was recorded.   
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Table 4: Clavien-Dindo Classification of surgical complications 
 Grades  Definition  
Grade I:  
 
 
 
 
Any deviation from the normal postoperative 
course without the need for pharmacological 
treatment or surgical, endoscopic and radiological 
interventions.  
Allowed therapeutic regimens are: drugs as 
antiemetics, antipyretics, analgesics, diuretics and 
electrolytes and physiotherapy. This grade also 
includes wound infections opened at the bedside. 
  
Grade II:  Requiring pharmacological treatment with drugs 
other than such allowed for grade I complications. 
Blood transfusions and total parenteral nutrition 
are also included.  
 
Grade III:  Requiring surgical, endoscopic or radiological 
intervention  
 
Grade III-a:  Intervention not under general anesthesia  
 
Grade III-b:  Intervention under general anesthesia  
 
Grade IV:  Life-threatening complication (including CNS 
complications: brain haemorrhage, ischaemic 
stroke, subarachnoid bleeding, but excluding 
transient ischaemic attacks) requiring IC/ICU 
management.  
 
Grade IV-a:  Single organ dysfunction (including dialysis)  
 
Grade IV-b:  Multi-organ dysfunction  
 
Grade V:  Death of a patient  
 
Suffix 'd':  If the patients suffers from a complication at the 
time of discharge, the suffix “d” (for ‘disability’) is 
added to the respective grade of complication. 
This label indicates the need for a follow-up to 
fully evaluate the complication  
 
 
 
Length of hospital stay (LOS): 
 
Time spent in the hospital after surgery is often used as a  tool to measure post-operative 
recovery(131) . Although various factors such as the help available at home, patients’ 
confidence with managing urostomy bags, catheters and drainage bags might also 
influence when the patient is discharged from hospital after cystectomy.  
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 2.3.4 Qualitative outcome measures: 
 
There are many definitions of a focus group in the literature. Some authors define a 
focus group as a group of persons who are invited by researchers to share their personal 
experience while participating in a group discussion (132). The authors further state 
that focus groups are a form of group interviewing that involves a number of people at 
the same time, with emphasis on the questions and responses between the researcher 
and interviewees. Other authors define focus groups as one who relies on the 
conversation and interaction within the group based on the topic introduced by the 
researcher. Focus groups have been documented to be an excellent method for data 
collection throughout the literature (133–135). Focus groups also tend to be useful in 
obtaining information on collective views, and deeper discussion of various viewpoints 
on a specific topic. They are also extremely useful in facilitating discussions of 
participants' experiences and values. Discussions are generally very rich. 
 
 Focus group meetings: 
 
Thirteen participants from the intervention group were purposefully sampled to 
participate in a total of 3 focus group meetings (at the end of the intervention and at 
least 6-8 weeks following surgery) based on their specific consent. All focus groups 
were conducted by Miss Kelly Semper (qualitative research analyst, University of East 
Anglia) and took place in private seminar rooms located at the Norwich and Norfolk 
University Hospital. For analysis purposes the focus groups meetings were audio 
recorded and this was also made clear to all participants on all information sheets prior 
to consenting. 
 
These focus groups aimed to gauge feedback on the intervention such as feasibility and 
enjoyment from the view point of participants. These focus groups were also aimed to: 
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 Consider which elements of the protocol were perceived as being most and least 
helpful. 
 
 Explore the participants’ perception of the effect that they think the exercise has 
had on their well-being and quality of life after surgery 
 
 Uncover any potential barriers or problems associated with the exercise protocol 
 
 Explore how this protocol could be refined and enhanced for use in larger scale 
interventions.  
 
Broad thematic analysis was used to elucidate experiences and views. The data was 
used to thematically sort and chart key themes and experiences. 
 
 
2.4 Statistical analysis  
 
Quantitative analysis 
 
Data collection and analysis was computed using SPSS ( SPSS Inc, IBM) .The data was 
tested for  normality of distribution ( using Kolmogorov-Smirnov test) .CPET data such 
as VO2 max and AT were found to be normally distributed as was demographic data 
and hence parametric tests were applied ( ANCOVA to compare variation in between 
groups) . Chi -Square test was done to compare categorical data. Post-operative stay in 
the HDU and length of stay in hospital were not normally distributed and hence non 
parametric tests were used. 
 
The significance level adopted was P < 0.05. Data is presented as the mean ± standard 
deviation. 
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Qualitative analysis: 
 
Thematic analysis is a method for identifying, analysing and reporting patterns within 
the data  through careful reading and rereading of the data (136) .This offers a flexible 
approach to analysing the data with the potential of gaining a rich and detailed 
account of patients’ experiences . Braun & Clarke (2006) propose 6 steps in thematic 
analysis;  
 
1) Familiarizing oneself with the data by transcribing the data, reading and re-
reading the data, noting down initial ideas. 
2) Generating initial codes 
3) Searching for themes;  
4) Reviewing themes: generating a ‘map’ of the analysis;  
5) Defining and naming themes;  
6) Producing the report: - the final opportunity for analysis  
  
These basic steps were utilised when analysing the focus group meeting data and 
deriving emergent themes. 
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Chapter 3: Results  
3.1 Feasibility Outcomes 
3.1.1. Recruitment rate 
 
112 eligible patients were approached to take part in the study between 01/07/2012 and 
01/07/2014. Of these, 53.5% (n= 60) patients agreed to participate and were recruited 
to the study.  
3.1.2 Reason for non-recruitment  
 
The Norfolk and Norwich University Hospital covers a wide geographical catchment 
area as it is a tertiary referral centre for the East of England for major urological surgery. 
The main reason for non-recruitment was distance the patients would have to travel 
from their home to the UEA exercise physiology laboratory. Although the patients who 
were in the control group had to travel twice (once for the initial assessment and again 
for the final assessment), the patients who were in the exercise arm had to make twice-
weekly trips to the laboratory every week for four weeks. As randomisation took place 
after baseline assessments were complete, the participants were not aware of group 
allocation. As such, all participants had to be willing to make multiple visits before 
randomisation. Most of the patients who declined participation in the study were from 
neighbouring areas such as Suffolk, and had to travel a considerable distance to take 
part in the trial. 73 % (n=38) of patients who refused to take part did so due to travel 
difficulties (fig. 5). 
 
A small number of people (n=3) who refused to take part did so because they felt they 
would be unable to undertake CPET assessment or comply with the exercise regime. A 
further four patients (7.6%) refused  to take part as they had an indwelling urethral 
catheter or a nephrostomy which they thought might prevent them from undertaking 
physical activity. Seven patients (13.4%) did not specify their reasons for non-
participation. 
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Figure 5: reason for non-participation 
 
  
Reason for non participation
38
3 4
7
0
10
20
30
40
geographical distance did not feel able to
undertake exercise
had an indwelling
catheter
reason not clear
Reason
N
u
m
b
e
r
 
o
f
 
p
a
t
i
e
n
t
s
52 
 
 
3.1.3 Compliance with randomisation:  
All recruited participants were willing to be randomised into either of the two groups, 
and no one withdrew consent following randomisation.  However, two participants in 
control group did not comply, participating in self-directed exercise after being 
randomised. 
 
3.1.4 Patient demographics: 
Of the 60 patients recruited to the study, 53 (88.3%) were male and 7 (11.7%) female. 
The mean age of the participants was 72 years (range 52-85 years). The mean age of 
the participants in control group was 72.5 (± 8.4) years and in the exercise group 71.6 
(± 6.7) years. The groups were matched for age and normally distributed (fig 6). 
 
 
Figure 6: Age distribution in Control and Exercise group 
*participant no 19 was an outlier in age distribution 
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Initial BMI distribution was similar across both exercise and control groups. The mean 
BMI in the control group was 26.9 (±4.4) and in the exercise group was 27.09(±4.2) 
(fig 7). 
 
 
 
Figure 7: BMI distribution between groups 
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3.1.5 Associated comorbidities: 
 
There was a substantial presence of comorbidities within the study population, with 
hypertension (56.6%), ischemic heart disease (IHD) (18.3%) and Type II diabetes 
(11.6%) being the most frequent. The distribution of comorbidities between groups was 
similar. An equal number of patients in both groups had hypertension (n = 17). Three 
patients in the exercise group and four patients in the control group suffered from Type 
II diabetes. Fewer patients in the exercise group than the control group had a history of 
IHD (n = 3 and n = 8, respectively; fig 8). 
 
60 % (n=15) of eligible patients in the trial had neoadjuvant (i.e. preoperative) 
chemotherapy. These patients were recruited at least 2 weeks after completing the last 
cycle of chemotherapy. Of these, ten patients in the exercise group and five patients in 
the control group had received chemotherapy. Of the 60 patients listed for cystectomy 
and recruited to the trial, 34 (56.6 %) had bladder cancer refractory to BCG treatment, 
25 (41.67%) had muscle invasive disease at presentation and one patient had squamous 
cell cancer (SCC) of the bladder.  
 
The prevalence of these comorbidities in the study population was similar to that found 
in the general population (137–141). 
 
 
  
Figure 8: Prevalence of comorbidities 
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3.1.6 Smoking habit: 
 
68.3% (n = 41) of patients were either current or ex-smokers. In both the exercise and 
control groups there were four current smokers, and 20 and 13 ex-smokers, 
respectively. Amongst the non-smokers 6 were randomised to exercise and 13 allocated 
to control (fig 9). 
 
 
 
Figure 9: Smoking habits 
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On comparison both the control and exercise groups were matched for demographics 
such as age, comorbidities, BMI, smoking habits and CPET parameters such as VO2 
max, AT, minute volume and Oxygen pulse at baseline assessment after randomisation 
(table 5). 
 
Table 5: Matching of control and exercise groups at baseline 
 Control Exercise p value 
demographics    
Mean Age 72.5 (± 8.4) years 71.6 (± 6.7) years 0.65 
Mean BMI 26.9 (±4.4)  27.09(±4.2).  0.87 
Hypertension(n=) 17 17 1 
Diabetes(n=) 4 3 0.68 
IHD(n=) 8 3 0.09 
Smoker(ex and current)(n=) 17 24 0.05 
    
CPET  parameters    
VO2 max 20.53 (±6.9) ml/kg/min  19.01(± 4.58) ml/kg/min 0.32 
AT 10.06 ( ± 2.7 ) ml/kg/min  9.01 ( ± 2.5 ) ml/kg/min 0.13 
Minute Volume (VE) 65.8 (± 20.82) L/min  71.35( ± 22.64 ) L/min  0.33 
Oxygen Pulse 10.9(± 2.7) ml/beat   11.1 (± 2.6) ml/beat 0.68 
    
 
 
3.1.7 Attrition /dropouts during trial: 
 
The overall compliance of the study participants was very good. After initial CPET 
assessment, 60 participants were randomised into equal groups. In the control arm 
25/30 participants completed both CPET assessments, which was similar in the exercise 
group (26/30) (fig 10).  
 
In the control arm, 28 patients had surgery and 2 patients elected for radiotherapy after 
randomisation. In the exercise arm, 27 patients had surgery and 3 elected for 
radiotherapy. Of these 5 patients in total, three elected for radiotherapy by personal 
choice, and 2 were deemed unfit by a consultant anaesthetist (one had PE and the other 
patient had pleural effusion). Post-operative data for these five patients was therefore 
not available. The patients who attended the initial CPET assessment but not the final 
assessment consented for post-operative data to be collected. 
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Figure 10: Consort flow chart  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5 : Consort flow chart of the study  
 
 
* As this was a feasibility trial in spite of protocol deviation all participants’ CPET data 
were analysed  
 
 
 
Assessed for eligibility (n= 112) 
Excluded (n=52) 
   Not meeting inclusion criteria (n=0) 
   Declined to participate (n= 52) 
   Other reasons (n= 0) 
Analysed (n = 30)  
 Excluded from analysis * (n= 0) 
 Did not have RC (n= 3)  
Allocated to intervention (exercise) (n= 30) 
 Received allocated intervention (n=23) 
 Did not receive allocated intervention 
(Dropped out of sessions at 
various times) (n=7) 
Did not attend repeat CPET (n=5) 
 Did not have RC (n= 2) 
 
Allocated to intervention (control) (n=30) 
 Received allocated intervention (n=26) 
 Did not receive allocated intervention (did 
not attend repeat CPET) (n= 4) 
Analysed (n = 30)  
 Excluded from analysis* (n= 0) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n= 60) 
Enrolment 
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3.1.8 Compliance with exercise:  
 
Adherence to the exercise protocol was very good. The median number of sessions 
attended by patients in the exercise arm was 8, which was the prescribed regimen as 
per the protocol.  In four patients surgery was delayed by longer than 4 weeks (because 
of unavailable dates for cystectomy) but these patients were very keen to carry on with 
the exercise sessions and attended two more sessions than planned.  Three patients on 
the other hand had cystectomy in under four weeks and were hence unable to attend all 
8 sessions as outlined in the protocol but attended for their repeat CPET assessment. A 
further eleven patients dropped out at various times over the course of the exercise 
programme (fig 11). These deviations from the protocol were noted. 
 
Figure 11: Number of exercise sessions attended by participants 
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3.1.9 Intensity of exercise during sessions: 
 
Participants’ mean heart rate (HR) during cycling exercise periods was 94.84 % (range 
92.69%- 96.1 %) of their peak heart rate as determined by CPET (table 5). The average 
percent heart rate across the weeks was calculated by the mean heart rate during 
exercise in that particular week divided by the peak heart rate achieved during CPET 
testing. 
 
This was accompanied by a median rating of 14 for perception of effort on the Borg 
scale.  
 
Table 6: Distribution of peak heart rate during exercise 
 Week 1  Week 2  Week 3  Week 4  Week 5  
Number of patients 30 27 25 20 4 
Mean percent HR  
(average HR in that week 
/peak HR at CPET )   
95.12 96.5 96.1 92.69 93.80 
Std Deviation 7.36 1.7 2.9 1.59 4.45 
 
 
 
 
3.2 Changes in CPET variables: 
3.2.1 Changes in VO2 max: 
 
The mean initial VO2 max (peak VO2 ) in the control group was 20.53 (±6.9) ml/kg/min 
and the mean initial VO2 max in the exercise arm was 19.01(± 4.58) ml/kg/min. On 
repeat CPET analysis before RC the VO2 max were 20.8 (± 5.4) ml/kg/min and 21.61 
(±5.5) ml/kg/min respectively. 
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Using univariate analysis (ANCOVA) it was found that the mean difference in the VO2 
max between the exercise and control group was 1.9 (0.87 – 3.00, 95% CI) ml/kg/min. 
(p=0.001) (fig.12). 
 
 
 
 
Figure 12: Mean difference in VO2 max between CPET testing sessions 
 3.2.2 Changes in AT (Anaerobic Threshold): 
 
The mean initial anaerobic threshold (AT) in the control group was 10.06 (± 2.7) 
ml/kg/min and the same in the exercise group was 9.01 (± 2.5) ml/kg/min. At repeat 
CPET assessment the mean anaerobic threshold in the control arm was 10.33 (± 2.46 
SD) ml/kg/min and in the exercise/exercise arm was 10.4 (± 1.87) ml/kg/min. Using 
similar univariate analysis (ANCOVA) to test the difference between the change of 
anaerobic threshold, it was noted that there was a difference of 0.33 (- 0.68 to 1.3,  
95%CI)  ml/kg/min  the (p= 0.5)  between the exercise and the control group before 
RC. (fig 13) 
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Figure 13: Mean difference in AT between CPET testing sessions 
 Looking at individual changes in AT in participants in exercise and control group 
respectively (figure 14 and figure 15) it appears that participants in exercise group had 
a steeper change in AT after 4 weeks. There were 2 participants in the control group 
who had participated in self-directed exercise and an improvement was noted in their 
AT as well. 
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Figure 14: Change in AT in exercise group 
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Figure 15: Changes in AT in control group 
 
 
 
 
3.2.3 Changes in VO2 (Oxygen consumption) 
 
The control group had a mean VO2 of 1538.07 ml (±511.7) initially and at the  
 repeat CPET testing, at the end of the study period, the mean was 1594.4 (± 461.3) ml. 
In the exercise arm the values were 1545.6 ml (± 438.3 ) and 1779.0 ml (±533.8) 
respectively. The mean difference between the exercise and control group was found to 
be 168.9 ml (95% CI 86.2 - 251.7) (p< 0.001) (fig 14). 
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Figure 16: Changes in VO2 
 
 
3.2.4 Changes in Minute Volume at VO2 max  
 
VE (minute volume) indicates the total amount of gas that is inhaled or exhaled per 
minute. Although in a normal adult it varies between 5 to 8 L/ min at rest the values are 
much higher when a person is exercising. In the current study the initial mean minute 
volume (at peak ?̇?𝑂2 and standardised BTPS) in the control group was 65.8 (± 20.82) 
L/min and the final mean value and end of the study period was 67.81 (±19.12) L/min. 
The mean minute volume in the exercise group initially was 71.35(± 22.64) L/min and 
increased to 79.96 (± 24.19) L/min at the end of the study period. The mean difference 
between the two groups was 8.10 (95% CI 3.5 –12.6 L/ min) L/min (p=0.001) (fig 15). 
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Figure 17: Mean difference in VE at VO2 max   between CPET testing sessions  
 
 
 
3.2.5 Changes in Oxygen pulse: 
 
Oxygen pulse denotes the oxygen uptake per heartbeat. The initial oxygen pulse in the 
control group was 10.9 ml/beat (± 2.7) and the final value at the end of the study was 
11.03 ml/beat (± 2.19). The values in the exercise arm were 11.1 ml/beat (± 2.6) and 
13.06 ml/beat (± 2.8) respectively. The mean difference between the two groups was 
1.60 ml/beat (95% CI 0.87- 2.3) (p<0.001) (fig16) 
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Figure 18: Mean difference in Oxygen pulse between CPET sessions 
 
 
 
3.3 Relationship between preoperative fitness level and post-
operative outcomes in the current study: 
 
In line with the published literature we looked at post-operative outcomes and 
associations between anaerobic threshold (AT). As the number of patients in this study 
was small (n=60) we chose to utilise the cut-off value of anaerobic threshold at 
11ml/kg/min as this has been proven in larger studies to predict favourable outcomes. 
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3.3.1 Length of stay in high dependency unit (HDU): 
 
All patients who undergo RC are routinely booked into HDU post operatively, for 
closer monitoring, at our institution. The mean length of stay in the high dependency 
unit (HDU) of those patients who had anaerobic threshold of more than or equal to 11 
ml/kg/min was 1.08 (± 0.28) days, range (1–2 days). The mean length of stay for 
patients in HDU who had anaerobic threshold of less than 11 ml/kg/min was 2.4 (± 2.2) 
days, (range 1-10 days) (fig 17). It was found that the length of stay in the high 
dependency unit was non-normally distributed and hence using Spearman's correlation 
analysis (non-parametric) there was found to be negative correlation of - 0.41 (p 
=0.002) between initial anaerobic threshold and length of stay in the high dependency 
unit indicating that patient with lower AT tend to stay longer in HDU. 
 
 
 
Figure 19: Mean length of HDU stay based on a cut off AT of 11ml/kg/min 
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The mean initial peak ?̇?𝑂2 of patients who stayed in the high dependency unit for one-
day (the minimum stay in HDU in our institution)  after operation was 22.17 ( ± 5.34 ) 
ml/kg/min compared to the mean peak ?̇?𝑂2 of 16.39 (± 3.90) ml/kg/min patients who 
stayed longer in the high dependency unit (fig 18) . Using the Independent t - test this 
difference appears to be significant (p <0.001) 
 
Using Spearman's correlation there is a negative correlation of -0.59 between the initial 
VO2 max and length of stay in the high dependency unit indicating similarly that 
patients with higher VO2 max stayed lesser number of days in HDU. 
(p<0.001) 
 
Figure 20:  Initial VO2 max and LOS in HDU 
 
 
 
69 
 
3.3.2 Need for inotropic support: 
 
Inotropes are medications that are used often in the high dependency unit to maintain 
adequate blood pressure in patients after major surgery. They need careful monitoring 
and hence are not suitable to be administered in a general ward. In the current study 
none of the patients whose anaerobic threshold was more than or equal to 11 ml/kg/min 
needed inotropic support in the high dependency unit. On the other hand, 8 patients 
who required inotropic support, all had AT of less than 11 ml/kg/min (fig 19). Although 
not statistically significant (p=0.09) using the chi square analysis, there appears to be a 
trend suggesting that need for post-operative inotropic support could possibly be related 
to the preoperative anaerobic threshold.  
 
 
 
Figure 21:  Need for post-operative inotropic support and AT 
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Comparing those patients who needed inotropic support with those that did not, we 
found that the mean anaerobic threshold was 7.48 (± 2.3) ml/kg/min and 9.98 (± 2.5) 
ml/kg/min respectively. Using one-way ANOVA, the mean difference was found to be 
significant (p= 0.01) (fig 20). 
 
 
 
 
 
Figure 22:  AT and use of inotropes 
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The mean initial peak ?̇?𝑂2 of patients who needed inotropic support post operatively 
was found to be 14.36 (± 4.27) ml/kg/min whereas in those patients who did not require 
inotropic support, the mean VO2 max was 21.06 (± 5.1) ml/kg/min (p=0.001) (fig 21). 
 
Figure 23:  Need for inotropes and initial VO2 max 
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3.3.3 Post-operative ileus: 
 
Post-operative ileus (non-motility of the bowel) is a recognised complication and an 
important cause of morbidity after cystectomy or any other major abdomino-pelvic 
surgery. In the current study ileus was noted to be present if there was a delay of longer 
than 3 days in establishing oral intake or if the patient needed a nasogastric tube. 
 
Using the cut-off anaerobic threshold of 11 ml/kg/min, prevalence of ileus was found 
to be higher (n= 11) in those patients with a low anaerobic threshold compared to those 
(n=1) with a high anaerobic threshold, although this was not statistically significant (p= 
0.1) (fig 22). 
 
Figure 24: Incidence of post-operative ileus based on a cut off AT of 11ml/kg/min 
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In those patients that had post-operative ileus the mean anaerobic threshold was found 
to be lower (8.3 (± 1.6) ml /kg/min) compared to those patients that did not have post-
operative ileus (9.9 (± 2.8) ml/kg/min). Although not statistically significant (p=0.07) 
there appears to be a trend towards low anaerobic threshold and presence of post-
operative ileus. (fig 23) 
 
 
Figure 25: Initial AT and ileus 
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Comparing patients who developed post-operative Ileus versus those who did not it was 
found that the mean initial VO2 max was 16.44 (± 4.66) ml/kg/min and 21.05(± 5.4) 
ml/kg/min (fig 24). Using the one-way ANOVA the mean difference between these 2 
groups was found to be statistically significantly different (p=0.008) 
 
 
 
Figure 26: VO2 max and ileus 
   
 
 
 
 
 
 
75 
 
 
 
3.3.4 Chest infection: 
 
Using the same cut-off anaerobic threshold of 11 ml/kg/min, it was noted that the 
prevalence of chest infection was higher (n=4) in those patients who had low anaerobic 
threshold compared to those (n=0) who had high anaerobic threshold 
(p=0.2) (fig 25). 
 
 
Figure 27: Chest infection and AT cut off of 11 ml/kg/min 
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Similarly, the mean initial AT in patients who had post-operative chest infection was 
7.8 (±3.3) ml/kg/min compared to mean initial AT of 9.7 (±2.6) ml/kg/min in those 
patients who did not (p= 0.1) (fig26). 
 
 
 
 
 
Figure 28: Initial AT and chest infection 
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The mean initial VO2 max in patients who suffered from chest infection in the post-
operative period was 18.2 (± 6.4) ml /kg/min compared to 20.14 (± 5.5) ml/kg/min for 
those patients who did not have chest infection (fig 27). Although there was a slight 
difference between the two groups it was not found to be statistically significant  
(p= 0.4) 
 
 
 
 
Figure 29: Chest infection and initial VO2 max 
 
3.3.5 Prevalence of complications according to Clavien 
classification: 
 
The prevalence of postsurgical complications was more pronounced in those with a 
baseline anaerobic threshold (AT) of less than 11 ml/kg/min. In this cohort Grade I 
complications were seen in 5 (9.09%) patients, grade II in 9 (16.36%) patients, grade 
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III and IV complications in 1(1.67%) patient each and 2 (3.64%) patients died after 
surgery (grade V complication) (fig 28). 
 
In contrast in those patients who had anaerobic threshold of more than or equal to 11 
ml/kg/min at baseline there was only one patient who had Grade I post-operative 
complication and none had any other grade of complications. 
 
 
 
Figure 30: Prevalence of complications using Clavien classification in patients with 
an AT above or below 11 ml/kg/min at baseline 
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Similarly, the mean initial anaerobic threshold of patients who did not have any 
postsurgical complication was found to be higher (10.1(± 2.8) ml/kg/min) compared to 
those who had any postsurgical complications, where the mean initial anaerobic 
threshold was found to be 8.5 (± 1.9) ml/kg/min (p= 0.03) (fig29). 
 
 
 
Figure 31: Baseline AT and presence of post -surgical complication 
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Those patients who had uncomplicated and straightforward recovery after surgery were 
found to have a higher mean initial VO2 max of 22.04 (± 5.21) ml /kg/min compared to 
those who had some deviation from the normal (i.e. had Clavien score of one or more). 
The mean VO2 max in the later group was16.32 (± 4.21) (fig30). This difference was 
found to be statistically significant (p<0.001) 
 
 
 
Figure 32: Initial VO2 max and post- operative complications 
 
3.3.6 Length of stay in hospital: 
 
The median length of stay for the patients in the study population was 7 days. Median 
LOS in both the exercise and control groups were also 7 days. 
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 The mean length of stay in the hospital for patients with a baseline anaerobic threshold 
of more than or equal to 11 ml/kg/min was 8 days (range 5-14 days). Those patients 
with baseline AT of less than 11 ml/kg/min had a mean hospital length of stay of 13 
days (range 4-90 days). (p=0.2) (fig 31) 
 
Using Spearman's correlation analysis, it was seen that the initial anaerobic threshold 
had a negative correlation factor of -0.24 (p= 0.07) suggesting that there was a trend 
towards higher baseline AT and shorter LOS. 
 
 
 
 
Figure 33: LOS in relation to baseline AT of 11 ml/kg/min 
 
 
82 
 
Similarly using Spearman’s correlation there appears to be a strong negative link (the 
correlation coefficient being -0.59) between the day of discharge of the patient from the 
hospital and their initial VO2 ma. (p<0.001) suggesting that patients with poor 
cardiorespiratory fitness tend to stay longer in the hospital (fig 32). 
 
 
Figure 34 Correlation between LOS and initial VO2 max 
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3.4 Effect of preoperative exercise on post-operative recovery: 
 
In this section it was analysed whether a short period (4 weeks) of preoperative exercise 
according to a protocol led to any changes in the post-operative outcomes and whether 
there was any appreciable difference in the post-operative outcomes between the 
“exercise” and “control” groups. Although it is recognised that the study was 
underpowered to look into these relationships and hence these outcomes were not 
primary outcomes for the study. 
 
 3.4.1 Length of stay in HDU: 
 
There was no statistically significant difference between the length of stay in the high 
dependency unit between the control and exercise group patients. The mean length of 
stay in both groups was 2 days (range 1-7 days in control and 1-10 days in exercise 
group). 
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 3.4.2 Need for inotropic support: 
 
In the control group 25% (n= 7) patients needed inotropic support compared to 7.4 % 
(n=2) in exercise group (fig 33). Although not statistically significant (p=0.07), 
comparing these two groups using chi square method, there appears to be a trend that 
people in the exercise group required less of inotropic support compared to the control 
group. 
 
 
 
 
 
Figure 35: Effect of group allocation on the need for Inotropes 
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3.4.3 Prevalence of post -operative ileus: 
  
There was very little difference in the prevalence of post-operative ileus between the 
control and exercise groups. 25 % (n=7) of patients in the control group and 23.07 % 
(n=6) patients in the exercise group suffered from post-operative paralytic ileus. (p=0.8) 
(fig 34) 
 
Figure 36: Effect of group allocation on post-operative ileus 
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3.4.4 Incidence of Chest infection:  
 
Incidence of chest infection was also similarly distributed between the two groups. 
7.14% (n=2) patients in the control group and 11.1% (n=3) patients in the exercise 
group were found to have post-operative chest infection. (fig 35) 
 
 
 
Figure 37: Effect of group allocation on incidence of chest infection 
 
3.4.5 Incidence of complications: 
 
39.28% (n=11) patients in the control group had some deviation from the normal post-
operative course of recovery (i.e. had a Clavien score of Grade I or more) compared to 
33.33 % (n=9) in the exercise group (fig 36). There was no statistically significant 
difference between these two groups (p=0.8).Considering the common factors known 
to influence post-operative recovery after RC, such as estimated blood loss (EBL) 
during surgery and operating time, the groups seemed to have been evenly matched 
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with no statistically significant difference (0.8 and 0.2) (142). The mean blood loss and 
operating time in the control group were 811(±717) ml and 310 (±59) minutes 
respectively. In the exercise group the EBL and operating times were 603(±306) ml and 
327 (±61) minutes respectively.  
 
Looking at the 30-day readmission rates it was noted that 12.7% (n=7) of patients 
having had RC were readmitted after discharge of which 4 (7.2%) were in the exercise 
group and 3 (5.5%) were in the control group. 
 
 
 
Figure 38: Post op complications and group allocation 
 
 
 
 
 
88 
 
3.4.6 Length of stay (LOS): 
 
The mean day of discharge from the hospital was 12 (±14) days (range 4- 78 days) in 
the exercise group compared to 15 (± 24) days (range 5-107) days in the control group 
(fig 37). The median length of stay in both groups were equal at 7 days. Using the 
Independent sample Mann Whitney U test there is no statistically significant difference 
(p= 0.8) between the length of stay between these two groups. 
 
 
 
 
Figure 39: LOS and group allocation 
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3.5 Qualitative analysis and focus group meeting outcomes 
3.5.1 Research Design & Participant Description: 
  
The patients who had participated in the exercise group (n=30) were approached at least 
six weeks after they have recovered from their surgery to see if they would be willing 
to attend a focus group meeting to share their thoughts about preoperative exercise. 
Based on their availability 15 participants were chosen to attend the focus group 
meetings. 13 participants eventually attended as 2 could not attend, due to last minute 
work commitments. Partners of the participants were also free to join these meetings as 
it was noted that during the exercise sessions some patients had attended with their 
partners to the exercise physiology laboratory at the UEA. Two of the participants who 
attended were female and the remainder male (n=11). Three partners (1 male and 2 
females) of the participants also attended and shared their thoughts. 
3 focus group meetings took place in total to keep the number of participants in each of 
the group around 4-5. As the study had staggered recruitment, spreading the focus group 
meetings also ensured that all meetings took place less than three months after the study 
finished in order to minimise recall bias. 
 
3.5.2 Setting: 
 
The participants were invited to come to Norfolk and Norwich Hospital education 
department seminar rooms, where the interviews were conducted.  The place of the 
interview was deliberately distinct from the exercise physiology laboratory where the 
patients had attended regular exercise sessions, avoiding either negative or positive 
associations with a particular site or building. 
 
3.5.3 Data Collection Procedure: 
 
The interviews were conducted by Kelly Semper (qualitative research analyst who was 
not directly involved in the trial) and Prof John Saxton (supervisor to the PI). The 
principal investigator (SB) or any person involved directly with the participants in 
administering the exercise session or conducting the CPET were not present during the 
interview. All the three focus group meetings were recorded and later transcribed. 
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The focus group meeting was conducted using open ended questions to glean out 
maximum information possible regarding the experience the participants had during the 
exercise sessions. The participants were also encouraged to interact with one another 
and share their views. The conductor of the focus group meeting ensured that the 
discussion focused mainly on the preoperative phase and exercise sessions, although 
they were also free to express any thought they had about any perceived benefits or 
harm from the exercise sessions before the surgery. 
 
 
 
 3.5.4 Thematic analysis of focus group data:  
 
Detailed analysis of the data revealed the overwhelming message that the exercise 
programme was seen as a positive experience by the participants. They not only 
perceived a physical benefit with the exercise but also a significant psychological 
benefit; they were doing something to help themselves get better, influencing some 
control over the outcome of their operation when at the time of a cancer diagnosis the 
feeling of having any control is often lost. 
 
Five main themes were identified which emerged during data collection and further 
analysis; “Motivation”, “Perceptions” “Relationship with the Health Care 
Professional(HCP)” “support” and “the experience of the exercise sessions”. Within 
these 4 main themes we found sub themes which we coded as such (see maps). We will 
now report each theme individually, supported by the words of our participants. 
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Main themes map 
 
 
 
  
EXERCISE 
PROGRAMME
Motivation
Support
Relationship with 
HCP
Experience during 
the trial
Perceptions/beliefs
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3.5.4.1 Theme 1: Motivation (influencing/controlling own 
destiny): 
 
 
The participants in this study were clearly self-motivated. They were keen to participate 
and to do anything which would help improve their recovery. They tended to have a 
positive approach to the forthcoming surgery, and were motivated to get better. The 
following quotes from the participants in the focus groups (fg) demonstrates this 
finding. 
 
“….it’s a fairly major serious operation and anything that would help to recover…” 
(Ron focus group 2 (fg2))  
 
.“….I pushed myself harder to get better, I was fairly fit anyhow, but I pushed myself 
harder to get there” (Rodney fg2) 
 
“……and I was already trying to get myself fairly fit before you know walking and 
doing a bit of exercise because I thought that it would all help afterwards and when I 
was approached and asked to do this trial I thought it was brilliant absolutely brilliant, 
so I was really pleased that I got the exercise” ( Pat fg3) 
 
“….they'd say well lets have another weight on and see what you can do, cos I was 
determined when they did that to still keep up to say 50-60 revs per minute you know” 
(Raymond fg3) 
 
“it's definitely a big help because you know yourself that when your heart's pumping 
and you feel better don't you and when you finish you just think that's brilliant you 
know I really enjoyed that…..when you've got a really good reason to do it that makes 
you more positive and you know that hopefully it's going to help you it's a really good 
reason to do it isn't it you've got a definite goal” (Pat fg3) 
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Others also helped to motivate the participant. Encouragement from supervisors leading 
the exercise sessions had a positive influence and motivated some participants to keep 
going. 
 
“I had  chemotherapy and that really made me feel ill and so I was even worse I didn't 
want to do much at all then, but going up there every week and meeting two people 
who I got on well with who are very friendly and that was motivation I think as much 
as anything”( Brian fg1) 
 
“they worked with you” (Brian fg1) 
 
“…if you get on well with the instructors you're 99% of the way there, there's no doubt 
about that” (Roger fg2) 
 
“It's good to have somebody measure your progress” (Trevor fg2) 
 
“The good part was the instructors spent all the time we were there all their time with 
us and that was very encouraging” (Trevor fg2) 
 
“…the encouragement of the people making you, go on a bit more a bit more that was 
a big help cos I was ready to say I can't do anymore, but they just gee'd you on” (Clifford 
fg3) 
 
“yeah they were very good with you know go on just a bit more” (Sheila fg3) 
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3.5.4.2 Theme 2:  Participants perceptions/beliefs: 
 
 
 
 
 
Participants’ belief about their baseline physical fitness: 
 
The general theme in the focus group meeting was that the participants perceived 
themselves to be fairly fit pre operatively. Many already did regular exercise for 
Motivation SelfOthers
participants
perceptions
/beliefs
physical benefits
psychological 
benefits
general fitness
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example walking dogs (Roger fg2) playing golf (Robert fg1) playing bowls (Ken) 
regular walking (Pat), cycling (Raymond fg3)or had an active job –(Brian fg 1 and 
Colin fg1). 
“…..i thought I was fairly fit until I got on that bike.” (Colin fg1) 
 “But I've always been fit all my life..” (Robert fg1) 
“I was quite fit cos I used to jog and I think I went up about 12% or something like 
that” (Trevor fg2) 
“I work all day long normally” (Raymond fg3) 
 
“Brian had a very physical job which had kept him fit all his life but he had given up 
work and the chemotherapy had made him feel quite ill, he describes getting out of 
breath even going to the shops but he could feel his fitness improving during the study” 
( Brian’s wife fg1 ) 
 
“……I knew I was very unfit, so it was going to be hard to start with especially during 
the chemo, but after the chemo I could feel myself getting better on the bike you know 
we were doing what was it a minute or 2 minutes each session and I knew from the start 
when I started to when I was like on the last one how much better that was for me…..” 
(Brian fg1) 
 
Belief about the Physical benefits of exercise programme: 
 
Physically many participants felt themselves improving their fitness with the exercise 
sessions. 
 
“….the first time I couldn't do it, I did one 5 minute interval, but by the end of the 
process after about 3 sessions I was doing more and with weights on” (Rodney fg2) 
 
“I thought it was very beneficial………… I couldn't have done it, had the op without” 
  
“….because the test of my heart rate and everything was better after the exercises” 
(Clifford fg3) 
 
“….you could see yourself getting better each week” (Pat fg3) 
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“you could yeah” (Clifford fg3) 
“going a bit further, a bit faster” (Sheila fg3) 
 
“…you didn't puff you weren't puffing so much” (Clifford fg3) 
“..yeah that's right” (Sheila fg3) 
“…felt better near the end” (Robert fg1) 
 
Although not everyone saw physical improvement which they found disappointing 
 
“I was a bit disappointed actually because having done the initial test and then gone 
through all the exercises the results were almost exactly the same.………. He said the 
problem is you were already fairly fit before you started and so he said that sometimes 
happens” (Ron fg2) 
 
 
Belief about the Psychological benefits: 
The benefits of taking part and improving physically also had an effect on the 
participants’ psychological well being 
 
“Oh yes it gives you a lift doesn’t it, it obviously helps you if they tell you that you've 
improved that you know your health has improved to that extent you feel satisfied” 
(Ken fg1) 
 
“Well I think it actually gave me a bit more confidence for the operation because of 
course you are going to be worried if you have been diagnosed and I thought well if 
they have put me on the exercise programme perhaps it's not as bad as they thought, so 
it actually gave me confidence to be on the exercise group …….” (Roger fg2) 
  
It helped the participants feel good doing something to help themselves. 
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“you feel better” (Pat fg3), 
 
 “mentally encouraging” (Trevor fg2)  
 
“You’re thinking you’re doing something good you’re helping yourself for the 
operation” (Ron fg2) 
 
“I think it's something that you can do to help yourself when there's not much else you 
can do, but you did feel you were trying to do something to make it more successful” 
(Pat fg3) 
 
Some described it as the logical thing to do to try to improve their fitness before major 
surgery. 
 
“….logical that if you make yourself fit you’re going to have a better time getting 
through the operation” (roger fg2)  
 
“it’s a known fact people always say………they say the fitter you are the more you 
recover” ( Brian’s wife fg2) 
 
For others it acted as a diversion, filling in the time whilst awaiting their surgery. 
 
“It filled in the time you are waiting to go in for a large operation.  It fills the time in 
that's one small part, but for me that was a big part it filled the time in, I had 2 or 3 
weeks going to the gym, quite enjoying it because prior to that I used to go to the gym 
anyway, so I didn't really find it that difficult, but it filled the time in nicely until the 
day came when you had to come in to hospital to have the operation.” (Colin fg1) 
 
Ken agreed with this “…it took your mind of it, yeah” (ken fg1) 
“you feel as if you’re doing something to prepare yourself for the big day rather than 
sitting and waiting for it” (Trevor fg2) 
 
“..yeah, but I think that helped because it's something else to take your mind off of it a 
bit isn't it” (Raymond fg3) 
98 
 
 
Others didn’t worry so much and were able to keep themselves occupied. 
 
“…..I kept myself occupied cos there's no use keep thinking about it cos you've got to 
have it done” (Robert fg1) 
. 
“I've never been a worrier, I'm not an emotional person and my glass is always half full 
always, so I actually didn't even think about my operation until the morning I went in.  
It just didn't cross my mind as to what was going to happen.  As far as I was concerned 
I was just going in to hospital and that was it.  People kept saying to me aren't you 
worried about going in and I said no…..” (Brian fg1) 
 
 
 
 
3.4.5.3 Theme 3: Relationship with the HCP/recruitment: 
 
We observed that the relationship with the healthcare practitioner (HCP) played a part 
in the participants’ decision to take part. Trust in the HCP was demonstrated by the 
following statements 
 
Relationship 
with HCP
Wanting to 
please
Trust
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“…so if a medical person says get fit and you’ll possibly have a better outcome after 
operation then I think I’ll do it” (Colin fg1) 
 
“…when it was explained to me what it would do that it would probably help recovery, 
although I felt able to recover anyway anything that could help does encourage you.  If 
somebody says something is going to help you then you know you take that advice” 
(Brian fg1)  
 
“…. well I mean the Doctor tells you well I'd like you to do these things and you just 
would normally believe in what he says is good for you…you don't go against them 
otherwise that would be silly” (Raymond fg3) 
 
 
“I think we've become attuned to well medical people say things and you take it as read” 
(Ken fg1) 
 
“…..my own doctor was keen on it for starters” (Roger fg2) 
 
 “..my own GP has always backed me 100% right the way through whatever I wanted 
to do he said yeah you do it” (Roger fg2) 
 
“…and seeing the doctors “as gods” (colinfg1), “respecting their knowledge” (Brian 
fg1) as “they’ve had years of training” (Colin fg1) 
 
Wanting to please the HCP was also demonstrated in the focus group meetings 
repeatedly. 
 
“….when Mr Rochester first saw me and told me I was going to need this operation he 
sold this thing to me then and you're not going to say “no” are you?.............you're not 
going to say no to a bloke that in a few weeks is going to open you up and take your 
bladder out are you?” (Colin fg1) 
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“Mr Banerjee came to see me and asked me if I would participate in this exercise or in 
exercise to improve my health before the operation and to see what the recovery time 
was afterwards, so I said yes well I'll do anything like that to help obviously” (Ken fg1) 
 
Focus group 3 were asked directly if it helped that a HCP was asking then to take part 
in the study, all agreed that it was influential in their decision to take part. 
 
“Mr Banerjee was very cordial and told me all the benefits it was very good, yeah I 
think that was a big help” (Clifford fg3) 
 
“I think it was good it was Doctor Banerjee and also we learnt a lot of information from 
him about the operation because he is a Urologist isn't he so he can answer a lot of 
questions and talk to us and it was really useful having the conversations with him, we 
learnt a lot” (Pat fg3) 
 
3.5.4.4 Theme 4: Support from family members:  
 
Results showed that many of the participants were well supported by their spouse or 
family member in both taking part in the trial as well as recovery from the surgery.  
 
“I think if it wasn't for my wife I think I would be struggling still” (Robin fg2) 
 
“……my wife is extremely supportive, so it helps….”(Ron fg2) 
 
“Whenever I complained about anything ……..my wife would say look you're alive” 
(Ron fg2) 
 
“…..you know when he doesn't feel like doing something you must, you must you know 
and it's really hard work” (Sheila fg3) 
 
“I was finding it hard to get out of my chair one Sunday and if she hadn't kicked my 
butt I wouldn't do things” (Clifford fg3) 
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Some wives or a family member accompanied their husbands to the lab and even took 
part, (Robin’s wife) others encouraged their husbands to continue the exercise at home 
 
“I just sat and watched, but I was there” (Clifford’s wife Sheila fg3) 
 
“…my daughter came with me to most of them… she was there and very supportive,” 
(Pat fg3) 
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3.5.4.5 Theme 5: the overall experience of participation in the 
exercise programme   
 
All the participants when asked about their experience of the study had only positive 
comments to make. “Good” (Colin 1, Robert  1, Robin 2, Barry 3), “enjoyable” (Barry 
3, Ron 2, Roger 2, Trevor 2,) “good fun” (Ray 3) “interesting” (Brian 1) “helpful” ( 
Colin fg1 ,Vincent fg3 ,Pat fg 3). 
 
Vincent (fg3) commented that “starting is the problem…….doing it in the first place 
that’s the difficult bit”. 
 
  Mostly the participants would recommend it to others. 
 
“I would recommend it to anyone that needs it” (Clifford fg3) 
 
Some participants even commented that they had continued to carry out self-directed  
exercise following recovery from the surgery. 
 
“ I have started doing brisk walking as soon as I recovered ” (Brian fg1). Colin (fg1) 
agreed “ I am totally sold to this idea…I am definitely going to continue” 
 
Some felt that 2 sessions a week were about right (Trevor, Ron, Vincent) but others felt 
they could do more (Roger, Rodney, Trevor ,Clifford) 
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Chapter 4: Discussion 
 
4.1 The study population; representative of the target population 
being studied 
 
 In the study population the mean age was 72 years (range 52 -85 years). This was in 
line with the age distribution of patients who undergo radical cystectomy for bladder 
cancer (143). The study population also had an expected prevalence of co-morbidities 
and smoking habits. Hypertension (56.6%), Ischemic heart disease (IHD) (18.3%) and 
Diabetes (11.6%) were the most common disease observed in the participants.  This 
matches closely the prevalence of these common diseases in the general population 
between 60-80 years.  
 
68.3 % of the participants were either ex-smokers or were currently smoking. Smoking 
is a well-recognised risk factor for bladder cancer and not surprisingly a sizeable 
proportion of the study population had this habit at some point in their life. As expected 
there was a preponderance of male patients. There were a total of 7 female participants 
to 53 males.  
 
60% (n=15) of eligible patients i.e. those patients who had muscle invasive disease at 
presentation, had neoadjuvant chemotherapy. Published literature have shown that 
historically 1-17% of patients undergoing cystectomy were offered neoadjuvant 
chemotherapy. Recent trends however have shown an increase in utilisation of 
neoadjuvant chemotherapy to about 30- 57%. ((144) 
 
It was noted that the patients were similarly matched in terms of demographics such as 
age, BMI, smoking habits and prevalence of comorbidities. The distribution of fitness 
parameters at the start as determined by initial CPET analysis (i.e before randomisation) 
such as VO2 max, AT, VE and oxygen pulse were also similarly distributed in the 
control and exercise groups. This indicates that there is a possible causal relationship 
between the intervention (i.e preoperative exercise) and change in CPET parameters at 
the end of the study.  
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4.2 Feasibility outcomes recorded show that a randomised 
control trial is feasible 
 
The primary outcome measure for this study was to confirm whether a randomised 
controlled trial, looking at benefits of pre-cystectomy exercise or prehabilitation, is 
feasible or not. Patients undergoing cystectomy are often elderly, smokers with 
significant comorbidity. It was not yet clear whether such a group of patients would be 
willing or able to undertake preoperative physical exercise. 
 
Recruitment to the trial was satisfactory. Of the 112 eligible patients that were 
approached, 60 agreed to take part in the trial over a 2-year recruitment period. We 
postulate that the main reasons that the recruitment rate was so good at 53.3% was that 
it was a short intervention (4 weeks) and that eligible participants were first approached 
about the trial by their treating physician before being approached by the principal 
investigator. Thematic analysis of the focus group meetings confirmed that the patients 
felt motivated to do something in the preoperative time they had to influence the 
outcome of their surgery. They felt well supported by their family members and 
partners. Surprisingly many participants in the exercise group thought they were fit 
because of their active lifestyle (i.e. walking regularly or having a manual job etc.). 
After the CPET they were able to compare their fitness in relation to their predicted 
cardiorespiratory fitness levels which possibly acted as a motivational tool to get even 
fitter. Another recurrent theme during the focus group meeting was that participants 
perceived and believed that they had both a physical and psychological improvement 
following the exercise sessions which made them better prepared to undertake the stress 
of major surgery. 
 
When participants of the focus group meeting were asked to summarize their overall 
experience of the exercise programme, adjectives such as “enjoyable” “interesting” 
“good fun” and “helpful” were used. A number of the participants confided that they 
had started performing self-directed exercise following their recovery from radical 
cystectomy. Quite a few people in the exercise group felt that they would recommend 
preoperative exercise to friends and family if they were in the similar circumstances. 
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The main reason for nonparticipation as given by eligible patients was distance from 
the exercise physiology lab located at the University of East Anglia from their home. 
As highlighted previously, the Norfolk and Norwich Hospital covers a wide 
geographical area as it is one of the tertiary referral centres for bladder cancer in the 
East of England. For future larger multicentre study, the recruitment rate is likely to be 
higher if the exercise labs are located in different areas allowing easy access to the 
participants. Only a small minority of patients (5.7%) felt that they were not ready to 
undertake physical exercise on a regular basis as they had led a sedentary life. The other 
common reason for nonparticipation (in 7.6% of non-participators) was the presence of 
either catheters or nephrostomy tubes which patients thought might prevent them from 
either undertaking CPET analysis or regular physical exercise. Interestingly however 
two of the participants who had taken part in the trial had nephrostomy tubes and 
catheters. 
 
 
Although the trial participants were from an ageing population with a number of 
comorbidities no problem was encountered during the CPET analysis either at the 
baseline or after the four-week period. The participants understood the instructions with 
regards to achieving the maximum output while undertaking the incremental exercise 
on the cycle ergometer whilst undergoing CPET. Compliance with randomisation was 
very good. All participants were happy to be randomised into either of the two groups 
(exercise or control) and no one withdrew consent following randomisation due to 
unsatisfactory group allocation. 2 participants however in the control arm participated 
in self-directed exercise after being randomised. 
 
Retention into the trial was very good with low dropout rates. In the control arm 83.3 
% (n=25) patients attended both the initial and final CPET assessment where as in the 
exercise group 86.7 % (n=26) attended both. 2 patients in the control group and 3 in the 
exercise group did not have surgery at the end of the trial period and opted for 
radiotherapy instead, either as a personal choice or after being deemed unfit by the 
anaesthetists to undergo surgery.  
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Adherence to the exercise sessions as per the protocol was also very good, 66.7 % 
(n=20) participants attending at least four weeks of exercise sessions. 10% (n=3) 
participants had dates for cystectomy before four weeks and hence had their repeat 
CPET assessment before the planned 8 exercise sessions. A further 10% (n=3) dropped 
out during the trial from the exercise group after deciding to opt for radiotherapy. The 
rest of the patients (n=2) who did not complete four weeks of exercise did so because 
of lack of time in their day as they were both self-employed. Interestingly 4 patients 
requested permission to continue exercise sessions as their date for surgery was more 
than four weeks away. These patients had their repeat CPET assessment after the 
scheduled four weeks and had another CPET assessment just before surgery. During 
analysis only the first and the second CPET assessment values (i.e. four weeks apart) 
were used. 
 
Level of exhaustion as perceived by the participants during exercise sessions was 
recorded using the Borg RPE scale and all the participants were achieving scale of 13-
15 during the exercise sessions (suggesting that the participants found the exercise 
effort between “somewhat hard” and “hard”). In spite of exercising at quite close to 
their peak heart rate and moderate- high level of physical exhaustion there was no 
evidence of any adverse events in the participants during the trial.  
 
Different authors have utilised various cut-off levels to prescribe exercise for elderly 
cancer survivors (such as heart rate at AT, 60 to 80% of VO2 max etc.) The American 
College of Sports Medicine (ACSM) convened a panel of experts to review the 
available evidence supporting exercise prescription guidelines for cancer survivors 
(145). The panel concluded that cancer survivors follow the 2008 Physical Activity 
Guidelines for Americans (≥ 150 mins/week of moderate-intensity, or ≥ 75 mins/week 
vigorous-intensity aerobic exercise or an equivalent combination of moderate- and 
vigorous intensity aerobic exercise) for cancer survivors, yet few studies have tested 
this empiric prescription in a formal randomized controlled trial. There are no published 
guidelines as to safe and desirable level and intensity of exercise in cancer patients 
before major uro-oncological surgery. The current data shows that it is safe to exercise 
patients at close to 90% of their peak heart rate even in an elderly cohort of patients but 
further evidence would need to be collected to prove that this is the case. 
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4.3 Changes in CPET outcomes in the exercise group  
 
The CPET parameters (such as the VO2 max, AT, oxygen consumption, minute oxygen 
consumption at VO2 max and oxygen pulse) were found to be normally distributed in 
the study population and hence univariate analysis (ANCOVA) (with their baseline/ 
initial CPET variable at the start of the trial as the covariate) was utilised to look for the 
difference in variance in these parameters between the control and exercise groups. 
 
It was found that after the four weeks of exercise some of the CPET outcomes had 
improved in the exercise group in comparison to the control group. The mean VO2 max 
had increased by 1.9 (95% CI 0.87 – 3.00) ml/kg/min. (p=0.001) and the mean oxygen 
consumption (VO2) had increased by 168.9 ml (95% CI 86.2 - 251.7) (p< 0.001). 
Similarly, the minute Oxygen consumption at VO2 max had increased by an average 
of 8.10 (95% CI 3.5 –12.6) L/min (p=0.001) in the exercise group in comparison to the 
control group.  
 
Oxygen pulse which denotes uptake of oxygen per heartbeat was found to have 
increased by an average of 1.60 ml/beat (95% CI 0.87- 2.3) (p<0.001) in the exercise 
group. 
 
Anaerobic threshold (AT) had also increased by 0.33 (95%CI - 0.68 to 1.3) ml/kg/min 
(although this was not found to be statistically significant, p=0.5). 
 
These findings illustrate that despite the period of “prehabilitation” being short, the 
patients generally improved their cardiorespiratory fitness levels as assessed by CPET. 
There is very limited evidence investigating the role of short preoperative aerobic 
exercise with the view to improve post-operative recovery. A recent systematic review 
by Valkenet et al looking at 12 studies of patients undergoing joint replacement, cardiac 
or abdominal surgery showed that inspiratory muscle training in the immediate 
preoperative period reduces risk of postoperative pulmonary complications. The 
intervention (exercise) period in most of these studies also appear to vary between 2-6 
weeks, as preliminary results suggest that the maximal benefit is appreciated in the first 
few weeks after which the effect plateaus (146) . The intensity and modality (either 
inspiratory or aerobic exercise) of training are important aspect to consider to achieve 
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optimal outcomes (147). However, there does not appear to be a consensus amongst the 
authors about the type of exercise, frequency, duration and intensity that needs to be 
prescribed in the preoperative period. Of the various studies looked at in the systematic 
review there was a variety of interventions including inspiratory muscle training, 
strength training and or cardiovascular fitness training. While some interventions were 
unsupervised (home based) some partly and some fully supervised by physical 
therapists (148–151).We were not aware of any other study looking at the role of 
preoperative exercise in patients undergoing radical cystectomy. 
 
4.4 CPET assessment outcomes as a predictor for post-operative 
recovery 
 
Complications after major surgery has significant impact on short and long-term 
mortality and morbidity. (152) A recent study of 6577 patients undergoing RC, showed 
that even one postoperative complication may double the odds of postoperative death, 
with postoperative respiratory tract infections and systemic infection having the most 
significant influence.(153). The use of cardiopulmonary exercise testing (CPET) as a 
preoperative risk stratification tool for a range of non-cardiopulmonary surgery is 
increasing. The utility of CPET in this role is dependent on the technology being able 
to identify accurately and reliably those patients at increased risk of perioperative 
events when compared with existing risk stratification tools such as ASA grading.(80) 
 
Rationale behind using a cut off AT of 11ml/kg/min     
 
Older et al demonstrated an increased post-operative mortality and morbidity in elderly 
patients undergoing major abdominal and cardiothoracic surgery if they had a low 
preoperative anaerobic threshold. They also suggested that an anaerobic threshold of 
11 ml/kg/min seems to be the cut-off point beyond which there is a higher rate of 
cardiovascular morbidity and mortality (0.8% vs 18%).(82)  Wilson et al in 2010 after 
analysing a large number of patients from a different series undergoing major 
abdominal and cardiothoracic surgery (n=847) came to similar conclusions. They 
showed that a cut of AT of 11ml/kg/min was able to predict hospital mortality (AUC 
0.68, 95% CI 0.59 to 0.76) with a sensitivity of 88% and a specificity of 47%.(84) 
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Snowdon et al found that both AT and VO2 max predicted complications in 116 patients 
following major abdominal surgery. The optimal AT to distinguish those at increased 
risk of postoperative complications was found to be 10.1 ml/kg/min in their study.(154) 
In a recent study of 69 patients undergoing cystectomy Snowden et al demonstrated the 
optimal threshold value for the prediction of complications by AT to be 12 
ml/min/kg.(93) These studies show that, for intra-abdominal surgery, the AT is 
associated with postoperative outcome and has the capacity to predict morbidity and 
mortality with a reasonable degree of accuracy. Although there is no consensus amongst 
authors as to the absolute cut off of AT, it appears to be between 10-12 ml/kg/min. In 
fact in a recent systematic review Grocott et al recommended that an AT of 11 
ml/kg/min appears an acceptable threshold to use in a clinical setting to indicate 
increased perioperative risk following major intra-abdominal surgery.(80) 
 
 
Although the sample size is small in our study we looked at the relationship between 
preoperative CPET para meters and post-operative outcomes. As our study population 
had similar characteristics to the studies above (i.e. elderly and undergoing major intra-
abdominal surgery) rather than having to redefine a cut off AT we decided to use an 
AT of 11ml/kg/min as our cut off. These measures were recorded as secondary 
outcomes from the feasibility trial.  
 
In our institution there is usually a gap of 6 weeks between patients having neoadjuvant 
chemotherapy and RC, this is to allow for optimisation of physiological function before 
the further stress of surgery. Studies have shown an increase in complications when RC 
was performed too soon after neoadjuvant chemotherapy (155)(156). Only a small 
study till date has shown a poorer oncological outcome when cystectomy was delayed 
beyond 3 months (156). Hence at our trial we recruited patients after 2 weeks of 
finishing chemotherapy and once they were in the trial for 4 weeks ,their surgery was 
not delayed due to participation in the trial thereby minimising chances of cancer 
progression. 
 
We appreciate that several confounding factors such as the type of surgery, duration of 
surgery, blood loss and the expertise of the surgeon could all have a bearing on post-
operative recovery rather than just fitness itself. Two of the patients (3.6%) out of 55 
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who went for radical cystectomy eventually had open cystectomy whereas the rest had 
laparoscopic surgery. Three of the patients (5.4 %) had a neo bladder reconstruction 
and the rest had standard ileal conduit. It is well recognised that the type of surgery 
(whether minimally invasive or open) and reconstruction (whether standard ileal 
conduit or reconstructed neobladder) does have a bearing on post-operative recovery 
(157,158) . In the present study as the numbers were quite small it was difficult to 
statistically analyse these patients separately and come to any logical conclusion and 
hence were analysed together (n=55). The mean blood loss and operating time in the 
control group were 811(±717) ml and 310 (±59) minutes respectively. In the exercise 
group the EBL and operating times were 603(±306) ml and 327 (±61) minutes 
respectively and the groups were found to be evenly matched to avoid confounding. 
The CPET parameters used in this instance were the baseline (i.e. before the participants 
were randomised into any group) variables so as to avoid any role of preoperative 
exercise acting as a confounding factor in the analysis. 
 
 
Length of stay in HDU and need for post-operative inotropic support 
 
All the patients after cystectomy at our institution are normally transferred to the high 
dependency unit. The possible need for inotropic support is one of the main reasons 
why patients after major surgery such as radical cystectomy are transferred to the high 
dependency unit. 
 
 There was found to be negative correlation of - 0.41 (p =0.002) between initial 
anaerobic threshold and length of stay in the high dependency unit indicating that 
patients with lower anaerobic threshold ended up staying longer in the high dependency 
unit. Similarly, there is a strong negative correlation between the length of stay in the 
high dependency unit and initial VO2 max of -0.59 (p<0.001). The mean initial VO2 
max of patients stayed in the high dependency unit for one-day (the minimum stay in 
HDU) after operation was 22.17 ( ± 5.34 ) ml/kg/min compared to the mean VO2 max 
of 16.39 (± 3.90) ml/kg/min patients who stayed longer in the high dependency 
unit(p<0.001). 
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Comparing those patients in the current series of patients who needed inotropic support 
versus those that did not we found that the mean anaerobic threshold was 7.48 (± 2.3) 
ml/kg/min and 9.98 (± 2.5) ml/kg/min respectively (p=0.01).  None of the patients with 
the anaerobic threshold of more than 11 ml/kg/min needed inotropic support (p=0.09). 
 
Similarly, the mean initial VO2 max of patients who needed inotropic support post 
operatively was found to be significantly lower at 14.36 (± 4.27) ml/kg/min compared 
to that of patients who did not need inotropic support where the mean was 21.06 (± 5.1) 
ml/kg/min (p=0.001). 
 
These findings taken together support the notion that CPET para meters such as 
anaerobic threshold and VO2 max could help to risk stratify those patients were more 
likely to need more intensive high dependency unit support (i.e. longer length of stay 
in HDU) and inotropic support. With an ever-increasing burden on the resources such 
as high dependency unit beds this may help in planning and optimising utilisation. 
 
 
 
Post-operative ileus and chest infection 
 
After major abdominopelvic surgery such as radical cystectomy post-operative ileus 
and chest infection are common complications leading to increased length of 
stay.(159)(160) . In the current series of patients who developed post-operative ileus 
versus those who did not it was found that the mean initial VO2 max was significantly 
different at 16.44 (± 4.66) ml/kg/min and 21.05(± 5.4)ml/kg/min respectively (p<0.01).  
 
Apart from high VO2 max and post-operative ileus there does not appear to be any 
statistically significant link between CPET parameters and post-operative outcomes. 
This could be partially because of the fact that we are primarily dealing with small 
number of patients (n=55) and although not statistically significant there appears to be 
a trend which needs to be studied by a larger randomised controlled trial 
 
Deviation from standard post-operative recovery as per the Clavien Dindo classification 
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The Clavien classification of post-operative course of events is a well-recognised and 
accepted method of classification. We looked at the link between higher level of 
preoperative fitness as predicted by the CPET parameters and their post-operative 
outcomes.  
 
It was noted that in the current group of patients that prevalence of postsurgical 
complications was more pronounced in those patients who had an anaerobic threshold 
of less than 11 ml/kg/min. Grade I complications were seen in 5 patients, grade II in 9 
patients and grade III and IV complications in 1 patient each. 2 patients in this group 
died after surgery (grade V complication). In contrast amongst those patients who had 
anaerobic threshold of more than or equal to 11 ml/kg/min there was only 1 patient who 
had Grade I post-operative complication and none had any other grade of 
complications.  
 
Those patients who had uncomplicated and straightforward recovery after surgery were 
found to have a higher mean initial VO2 max of 22.04 (± 5.21) ml /kg/min compared to 
those who had some deviation from the normal (i.e. had Clavien score of one or more) 
who had a mean VO2 max of 16.32 (± 4.21) (p <0.01). Similarly, the mean initial 
anaerobic threshold of patients who did not have any postsurgical complication was 
found to be higher (10.1(± 2.8) ml/kg/min) compared to those who had any postsurgical 
complications (8.5 (± 1.9) ml/kg/min) (p=0.03). The differences were more stark when 
a Clavien score 3 or more (which are often considered to be clinically more significant 
after RC) were considered. The VO2 max was 14.6 (±6.3) ml/kg/min (p<0.001) and 
AT 7.9 (±1.9) ml/kg/min (p<0.001). These results indicate that clinically significant 
complications were more common in patients with worse cardiorespiratory reserve. 
 
These results indicate that a higher level of preoperative fitness may offer some degree 
of post-operative resilience with a greater physiological reserve to withstand post-
operative complications. Given the small number of patients that trend highlighted in 
the study needs to be further explored with a larger study. 
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Length of stay  
 
Length of stay in the hospital after surgery is an easy to measure post-operative outcome 
measure to look at the efficiency of an intervention. Although various other factors such 
as the type of surgery (open or laparoscopic), type of reconstruction (ileal conduit or 
neo bladder reconstruction), social circumstances like care available at home after 
discharge often play a role to determine when the patient is finally discharged home 
after radical cystectomy. On average in the UK patients stay in roughly 14 -17 days 
after cystectomy(93,161). . 
 
In the current study the length of stay of the patient post -surgery was non-normally 
distributed and hence nonparametric tests were used to look at the correlation between 
length of stay and CPET para meters. 
 
Using Spearman’s correlation there appears to be a negative link between the day of 
discharge of the patient from the hospital and their initial VO2 max. ((the correlation 
coefficient being -0.59) (p<0.001) and initial anaerobic threshold (correlation factor of 
-0.24  ( p= 0.07) ) suggesting that patients with poor cardiorespiratory fitness tend to 
stay longer in the hospital. The mean length of stay for patients with anaerobic threshold 
was lower than 11 ml/kg/min was 13 days compared to 8 days in those with higher 
anaerobic threshold (p=0.2). 
 
These results suggest that in spite of other confounding factors dictating the length of 
stay after surgery for patients, cardiorespiratory fitness could potentially act as an 
important predictor. The relationship between CPET para meters and length of stay 
need to be further explored. 
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4.5 Does preoperative exercise change post-operative outcomes 
 
 Given the small sample size of exercise and control groups (n=30, in each arm) post-
operative outcomes in relation to the intervention of preoperative exercise should be 
interpreted with caution. In fact, this was not one of the primary outcome of the 
feasibility study.  
 
There was no statistically significant difference between the exercise and the control 
group in relation to length of HDU stay (mean stay 2 days in both groups), post-
operative ileus (23.07% in exercise group vs 25% in the control group), incidence of 
chest infection (7.14% in control vs 11.1% in exercise group) or prevalence of Clavien 
complications (33.3 % in exercise group vs 39.2 % in the control group). 
 
The mean length of stay (LOS) in the hospital was 12 (±14) days (range 4- 78 days) in 
the exercise group compared to 15 (± 24) days (range 5-107) days in the control group 
(p=0.8). There was no difference in the median length of stay in either groups with both 
being 7 days. 
 
In the control group 25% (n= 7) patients needed inotropic support compared to 7.4 % 
(n=2) in exercise group during their stay in high dependency unit.  This indicative 
evidence of a trend for a difference between the groups in inotropic support (p=0.07) 
warrants further investigation in a properly powered randomised control trial 
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4.6 Current results and similar studies: what does the current 
study add 
 
This current study adds to the ever-increasing evidence suggesting that CPET testing is 
safe, reproducible and an effective method of assessing cardiorespiratory fitness. In 
spite of the test initially being developed for healthy athletes, Bisschop et al in their 
systematic review of 1158 preoperative cancer patients, demonstrated that the 
probability of adverse events from CPET testing was quite low. (1 %) (162). Lund et al 
in their systematic review of a large cohort of elderly (average age 70±5 years) patients 
suffering from heart failure found CPET to be quite safe (163). Similarly, in our study 
there were no adverse events noted during CPET. 
 
An increasing number of surgeons and anaesthetists are recognising the potential of 
using CPET as a risk stratification tool. The majority of the available literature indicates 
that CPET markers are associated with surgical outcome following non-
cardiopulmonary surgery, and that for many types of surgery CPET has the capacity to 
identify high risk patients. However, the optimal predictor of high risk appears to differ 
between surgery types, with AT shown to be the common indicator utilised to identify 
higher risk patients for major intra-abdominal surgery (80). In our current cohort of 
patients both AT and VO2 max correlate well with length of stay in HDU and need for 
inotropic support. In line with published literature our study also found that a cut off 
AT of 11ml/kg/min correlates well with presence or absence of complications. On the 
other hand, VO2 max correlated well with length of stay (LOS) and presence or absence 
of paralytic ileus.  
 
 Although the number of patients was quite small there is encouraging evidence from 
this study to suggest that a short period of exercise prehabilitation is well tolerated and 
is possibly able to change certain CPET parameters effectively. We were not aware of 
any similar studies looking at the role of preoperative exercise in patients undergoing 
radical cystectomy. A larger randomised controlled trial is needed to investigate 
whether this improvement in CPET parameters can translate into better post-operative 
recovery as well as reduce the length of stay for patients. 
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4.7 Strength and Weaknesses of the study 
 
This study was a well-executed randomised control feasibility study. The aims and 
outcome measures were clearly defined (i.e. the primary outcomes being feasibility 
outcomes and secondary outcomes being preliminary investigations of fitness and 
recovery parameters following RC and whether preoperative exercise can lead to an 
improvement in fitness). The participants were randomised according to a pregenerated 
randomisation sequence, with the exercise physiologists (BS and JS) running the CPET 
assessment as well as those interpreting the results of CPET analysis (JS and GC) 
blinded to group allocation. To avoid bias in qualitative analysis (i.e. focus group 
meetings) the interviews were conducted by a qualitative analyst (KS and JS) who were 
not directly known to the participants. The focus group meetings were held soon after 
the intervention (between 6 weeks and 3 months following surgery) to avoid recall bias. 
The place of the interview was deliberately kept away from the exercise physiology 
laboratory where the patients had attended regular exercise sessions, avoiding either 
negative or positive associations with a particular site or building. 
 
 
It is appreciated that the current study was a single centre randomised controlled 
feasibility trial and as such the results of the study have to be interpreted with caution. 
Some of the patients had surgery before their four weeks of exercise was completed 
and hence may not have achieved the full benefit of “prehabilitation”, similarly certain 
patients had delayed cystectomy and hence carried on with their exercise sessions till 
their surgery and stayed on the trial longer than anticipated. There were 2 patients in 
the control arm who participated in self-directed exercise during the trial demonstrating 
the potential for intervention contamination in single centre studies. Although small in 
numbers some patients had open cystectomy (n=2) as well as neo bladder (n=3) 
reconstruction both of which can independently influence post-operative recovery. 
Similarly other confounding factors such as preoperative smoking status, 
chemotherapy, different surgeons , level of IHD in participants which were not matched 
in exercise and control groups could  all have a bearing on recovery. 
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4.8 Future research 
 
The results of this   randomised controlled feasibility study are encouraging and suggest 
that a larger multicentre randomised controlled trial to investigate the role of 
preoperative exercise in patients undergoing radical cystectomy or any other major 
abdominopelvic oncologic surgery is warranted.  
 
It is plausible that a short course of preoperative exercise session for a few weeks could 
act as an adjunct in the enhanced recovery pathway for such patients. The mean length 
of stay (and SD) in days in the exercise and control groups were 12 (±14) and 15 (±24), 
respectively. This three-day difference did not reach statistical significance according 
to Mann-Whitney U test.  This was not unexpected given that the present work was a 
feasibility study. The relatively small sample size, combined with considerable 
heterogeneity in health status amongst the patients recruited, introduced the strong 
possibility that the study was underpowered. To inform future investigations, we 
calculated the number of patients required to be able to detect differences based on the 
magnitude of the effect size and power of this work. This was performed with the 
G*Power 3.1 power analysis suite (Faul et al., 2007)(164). Briefly, post-hoc analysis 
was conducted by Wilcoxon signed rank test and the effect size (dz) calculated, using 
the mean (SD) length of stay described previously, assuming an α error probability of 
0.05. This was then used to determine the achieved power (1 – β error probability) of 
the present study, which was ~ 0.19. The achieved power was then adjusted to 0.8 (80%) 
in an a priori analysis using a Wilcoxon signed ranks approach, assuming the same 
effect size (dz) and α error probability of the present study. According to this, the 
number of patients needed for a future investigation is 400, i.e. 200 per group. The 
calculations are provided as supplementary material in Appendix 1. 
 
The potential of enhanced recovery in cystectomy is huge. On an average an acute 
surgical bed day costs around £225 and with a potential reduction of 3 days this could 
amount to £675 per patient (165). The average HDU bed day cost is £1152 and better 
risk stratification of patients (i.e. identifying those patients less likely to need inotropic 
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support or level 2 care) could potentially help better distribution of limited resources 
(166,167). 
 
However, it should be noted that power calculations using this and other types of 
software assume a normal distribution of the parent data, which was not the case in our 
study. Also, based on the similarity of baseline characteristics of our patients between 
exercise and control groups (such as age, BMI, comorbidities, fitness levels, operating 
time and EBL) we assumed a ‘matched pairs’ design in the present work and future 
investigations. Taken together, it might be that our required sample size estimation is 
conservative.   
 
4.9 Conclusion : 
 
There is encouraging evidence from this study to suggest that a short period of 
prehabilitation before RC is well tolerated and is able to change certain CPET para 
meters effectively. It is plausible that a short course of preoperative exercise session for 
a few weeks could act as an adjunct in the enhanced recovery pathway for such patients. 
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Appendix :1 Power calculation to determine sample size  
 
1)  t tests - Means: Wilcoxon signed-rank test (matched pairs)  
Options: A.R.E. method 
Analysis: Post hoc: Compute achieved power 
Input: Tail(s) =Two  
Parent distribution=Normal Effect size dz=0.1436739 α err probability 
=0.05  
Total sample size=60  
Output: Noncentrality parameter δ=1.0875249 Critical t=2.0030085 
Df=56.2957795 Power (1-β err prob)=0.1877111   
 
2) t tests - Means: Wilcoxon signed-rank test (matched pairs)  
Options: A.R.E. method  
Analysis: A priori: Compute required sample size  
Input: Tail(s)=Two  
Parent distribution=Normal Effect size dz=0.1436739 α err prob=0.05 
Power (1-β err prob)=0.8  
Output: Noncentrality parameter δ=2.8114849 Critical t=1.9661947 
Df=381.9268 Total sample size=401 Actual power=0.8007905 
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Appendix 2 : Study protocol  
 
 
Preoperative Exercise Protocol to Aid Recovery (PREPARE) for Radical Cystectomy  
STUDY PROTOCOL VERSION 4 16.04.12 
Srijit Banerjee MB BS MRCS, Clinical Fellow in Urology, NNUH 
John Saxton, PhD, Professor of Clinical Exercise Physiology, UEA 
Robert Mills FRCS(Urol), Consultant Urological Surgeon, NNUH 
Mark Rochester MA MD FRCS(Urol), Consultant Urological Surgeon, NNUH 
 
Background 
 
Enhanced recovery protocols (ERPs), are a team approach to perioperative care for 
participants undergoing surgery. They minimize physiological stress caused by surgery 
and promote recovery. Significant reductions in hospital stay have been shown without 
increased complications or readmissions. ERPs decrease ileus, prevent loss of lean 
body mass, reduce atelectasis, promote oxygenation and preserve cardiovascular 
response to exercise after surgery. ERPs have spread from colorectal surgery to other 
surgical specialities. Components of an ERP are as follows: Preassessment is used to 
inform participants, to highlight and overcome psychosocial barriers to early recovery 
or discharge, and to trigger medical optimization if required. Participants receiving 
preoperative carbohydrate loading have an accelerated recovery and shorter hospital 
stay. Prevention of intraoperative hypothermia reduces sympathetic responses, cardiac 
arrhythmias and wound morbidity. High inspired oxygen level during the perioperative 
period increases intestinal oxygenation, reduces wound infection, and decreases 
postoperative nausea and vomiting. Goal-directed fluid therapy with oesophageal 
Doppler allows precise fluid balance, and this reduces surgical complications and 
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shortens length of hospital stay. Optimized pain relief allows early mobilization and 
opiate-sparing analgesia reduces nausea, vomiting and sedation. Epidural anaesthesia, 
is an important component of ERPs. Participants undergoing radical cystectomy are a 
particularly applicable group for ERPs, as the procedure is still associated with 
significant morbidity and a prolonged inparticipant stay by comparison with other 
operations. Implementation of an ERP for radical cystectomy in one UK centre reduced 
postoperative stay by 3 days, with no effect on morbidity or mortality.  
 
The major focus of the ERP literature to date has been on peri and post-operative care. 
Improving the outcome for these participants, however, could begin long before the 
participant arrives at the preoperative assessment visit. A surgical procedure such as 
radical cystectomy is associated with a catabolic state, similar to prolonged endurance 
exercise. An athlete would not attempt an endurance event without training, and it is 
our hypothesis that a period of preconditioning prior to major surgery in addition to 
enhanced recovery would be beneficial in a similar way for these participants. It is well 
known that physical functioning is a predictor of morbidity and mortality in various 
participant groups and among elderly people.  The same trend appears to be present in 
the surgical population. Surgery is a stressful event, and the recovery period after 
invasive surgery often involves bed rest, which in turn may induce loss of muscle mass, 
deconditioning, and pulmonary complications which can lead to decreased quality of 
life, increased morbidity, longer hospitalization and even death. It follows that optimal 
physical functioning of participants before stressful surgery might result in better 
postoperative outcome. Several studies have shown that the preoperative aerobic 
capacity of lung participants correlates with the rate of postoperative pulmonary 
complications after lung resection. Similarly, a significantly shorter length of hospital 
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stay after total hip replacement was reported in participants who were more physically 
active before the surgery. Optimal preoperative physical functioning of participants can 
therefore be an important determinant of postoperative functioning, complication rate, 
and length of hospital stay. A recent systematic review has shown that preoperative 
exercise therapy consisting of inspiratory muscle training or exercise training prior to 
cardiac or abdominal surgery leads to a shorter hospital stay and reduced postoperative 
complication rates.  
 
The Enhanced Recovery Partnership Programme has been recognised in the Quality, 
Innovation, Productivity and Prevention (QIPP) Challenge as a high impact example 
for change for the NHS. To date, work has focussed on optimising the post-operative 
course, and little work has focussed on pre-operative optimisation. 
 
Through PREPARE participants will become partners in their own care. It combines 
the existing ERP framework with rehabilitation plans and cutting- edge 
preconditioning. PREPARE  will reduce demand on HDU / ITU bed days, and shorten 
length of stay which in turn will reduce  exposure to hospital acquired infections, and 
because participants are fitter sooner they can return to normal activities earlier. If it 
can be demonstrated that this approach is effective for cystectomy participants we will 
work towards spreading this innovation to other high risk complex surgical groups, 
such as vascular participants, those undergoing oesophagectomy, or major bowel 
resections. 
 
Methods And Design 
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After ethical approval 30 participants will be recruited to each arm of this study. These 
will be the participants who have been listed for radical cystectomy for bladder cancer 
from the Urology Specialist Multidisciplinary Team meeting at the Norfolk and 
Norwich University Hospital. They will then be randomised to receive either a four 
week intensive exercise training according to a preset protocol, or the standard 
enhanced recovery pathway. Post operatively these participants would be monitored 
and their post-operative course charted, including time to passing flatus, tolerating diet, 
mobilising and discharge time. The frequency of complications in the post-operative 
period will be recorded according to the Clavien classification.  
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Assessment of cardiopulmonary fitness before and after the 4 week period of 
exercise training 
Incremental cycle ergometry test ( CPET assessment ) 
 
Participants will undertake a continuous, incremental cycling test to volitional 
exhaustion on an electronically-braked cycle ergometer (Excalibur Sport, Lode, the 
Netherlands). Pedalling frequency will be set at 50 revs·min-1. After a 5-min warm-up 
against minimal resistance (0 W), the intensity of exercise will be ramped up by 20 to 
30 W·min-1. Participants will be encouraged to continue cycling to volitional 
exhaustion or until a plateau in oxygen consumption is observed. Heart rate and 12 lead 
ECG will be recorded continuously by electrocardiogram (Cardioperfect, Welch Allyn, 
USA) and perceived exertion (Borg RPE Scale) will be assessed at 2 min intervals. 
 
The following parameters will be recorded; 
 
1. Maximal oxygen consumption (Peak VO2 ) 
 This will be calculated as the highest consecutive 20-second period of gas exchange 
data in the last minute before volitional exhaustion, which we expect to occur due to 
leg fatigue and/or breathlessness. 
 
2. Minute ventilation :   
The volume of oxygen consumed during exercise will be calculated from minute 
ventilation, measured using a pneumotach, and simultaneous breath-by-breath 
analysis of expired gas fractions (Ultima CardiO2, MedGraphics, USA). Gas analysers 
and flow probes will be calibrated before each test. Oxygen consumption will be 
expressed relative to body mass (mL·kg-1·min-1) 
 
3. Anaerobic threshold : 
This will be derived using the ventilatory slope method. 
 
4. O2 pulse :  
This parameter approximately equates to stroke volume and may reflect 
cardiovascular disease or ventilator constraint. It is measured as VO2 /Heart Rate. 
 
5. VO2 / power slope :The relationship between oxygen uptake and work rate (in 
watts). It is reduced in any condition that reduces blood flow to the periphery and is 
not affected by obesity. 
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Criteria for termination of CPET assessment : 
 
1. Contraindications where CPET would not be initiated: 
 Acute endocarditis, myocarditis, pericarditis  
 Severe, symptomatic Aortic Stenosis  
 Acute MI in the last 6 months 
 Unstable Angina 
 Undiagnosed arrhythmias 
2. Reason for termination during CPET : 
 Patient’s request: fatigue, dyspnea, pain 
 2nd or 3rd degree heart block or any new arrythmia 
 BP sys>240-250, BP dias >110-120 
 
 
 
Exercise protocol:   
 
Participants will attend an exercise physiology laboratory at the University of East 
Anglia for supervised exercise sessions comprising 45-60 min of aerobic exercise 
(intensity of 60-80% of peak power output achieved in the incremental cycle ergometry 
test. Participants will perform 6x5 min bouts of exercise at this intensity, with 
interpolated rest intervals of 2.5 min. Each exercise session will include a 5 min warm-
up and 5 min cool-down.   
 
This will consist of the following : 
 
1) Warm Up : 5-10 min 
 
 
2) Cycle ergometry exercise : 6 x 5 min intervals at 60-80% of peak power output 
achieved in the incremental cycle ergometry test. Each interval will be followed 
by a 2.5 min rest period. Heart rate and ratings of perceived exertion will be 
recorded in the final minute of each interval. Exercise intensity will be 
progressed at an appropriate rate for each individual.  
 
3) Cool Down : 5-10 min 
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 In addition they will be instructed to undertake self-directed aerobic exercise (e.g. brisk 
walking, cycling, gym exercise) for at least one 30 min session per week during this 
time period. All exercise sessions will be recorded in an exercise log. The participants 
will also be supplied with portable pedometers which they will use as a motivational 
tool during these self-directed exercise sessions and the distances travelled will be 
logged electronically. 
 
The participants will also be asked to fill up a quality of life questionnaire using the 
pre-validated and standard FACT–BL questionnaire. This is a disease specific 
questionnaire that looks at various aspects of the participant's quality of life including 
physical well-being, social or family well-being, emotional well-being and functional 
well-being. The participants will be filling up the questionnaires at the start (weeks 0) , 
at week four ( that is at the end of intervention) and at 6 weeks post operative ( at the 
time of their follow-up).  
 
 
Qualitative analysis : 
Approximately 8-10 people from both the intervention and control group will be 
purposefully sampled to participate in 2 focus group meetings (at the end of the 
intervention and 6-8 weeks following  surgery) based on their specific consent. All 
focus groups will be conducted by Miss Kelly Semper ( qualitative research analyst, 
University of East Anglia) and will take place in private seminar rooms located at either 
the University of East Anglia or the Norwich and Norfolk University Hospital. For 
analysis purposes both focus groups will have to be audio recorded and this will also 
be made clear on all information sheets prior to consenting. 
These focus groups will aim to gage feedback on the intervention such as feasibility 
and enjoyment from the view point of both exercise and control group participants. 
These focus groups will also aim to: 
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 Consider which elements of the protocol were perceived as being most and 
least helpful. 
 Explore the participants’ perception of the effect that they think the exercise 
has had on their well being and quality of life after surgery 
 Uncover any potential barriers or problems associated with the exercise 
protocol 
 Explore how this protocol could be refined and enhanced for use in larger 
scale interventions.  
Broad thematic analysis will be used to elucidate experiences and views. Initial analysis 
will sort the data thematically and chart key themes and experiences. Final analysis will 
compare key themes across the two groups of participants, exercise and control.  
 
Recruitment of participants for the study   
All participants who would be offered radical cystectomy as part of treatment for 
bladder cancer would be deemed suitable to be recruited for the study. Currently the 
participants are seen in the clinic following the urology SMDT by a consultant urologist 
to discuss the option of surgery. We aim to recruit the participants at this point and 
utilise the interval prior to surgery which is currently 4 weeks for the intervention. The 
majority of participants under 80 years of age have been through a period of 
neoadjuvant chemotherapy and have a window of opportunity of 4 weeks after their 
third cycle of treatment before they are ready for surgery to allow them to participate 
in the exercise programme. Those that are not suitable for chemotherapy will still have 
a 31 day window in which the preconditioning can take place. 
 
Suitable participants will be offered the opportunity to join the study, and given a 
participant information sheet. They will then be contacted within 24 hours by the 
principal researcher for this project, Mr S Banerjee who will be able to answer any 
queries which are raised prior to obtaining informed consent and enrolment into the 
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study. Participants are free to withdraw from the study at any point without subsequent 
delay to their surgery or alteration of their management plan. 
 
 
The participants would not have any financial incentive as part of being recruited for 
the study, although subject to fund availability we would try to reimburse the travel 
expenses that are incurred. 
Consent : 
The participants who would be recruited for the study will have to sign an informed 
consent. They will be supplied with an information leaflet about the study and would 
include the contact details of the principal researcher whom they can contact at any 
time before or after they enrol for the study to answer any queries. Participants would 
be given at least 24 hours to read the documentation before being asked whether or not 
they wish to take part.  
 
Place and details of the study 
The participants will undergo a supervised 4 week cycle of supervised cardio 
respiratory exercise at the physiology laboratory at the University of East Anglia 
(UEA). They will be asked to come to the laboratory twice per week for 4 weeks and 
would undergo a protocol based set of exercises . The exercises would last a total of 1 
hour and would be tailored to the individual participant’s background exercise 
tolerance: a participant with a higher baseline cardiorespirarory reserve would therefore 
be prescribed a more intensive cardio respiratory exercise than a peer with lower 
baseline fitness. At all times the intervention would be supervised by a qualified 
medical practitioner. In addition they will be instructed to undertake self-directed 
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aerobic exercise (e.g. brisk walking, cycling etc.) for at least one 30 min session per 
week during this time period. All exercise sessions will be recorded in an exercise log.  
 
At the beginning and end of the study the participants would undergo cardio respiratory 
fitness assessment to assess any improvement in the exercise tolerance. 
 
 
Risks : 
 
Exercise sessions at the UEA  will be supervised by a medical practitioner The exercise 
protocol will be also tailored to the individual participant taking into account their 
background medical conditions and would only take them upto 85% of perceived 
exhaustion as predicted on the Borg RPE scale. The protocol of exercise will be 
designed by Prof John Saxton (Professor of Exercise Physiology at the UEA). 
  
 
Conflict of interest 
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Appendix 3 : Patient information leaflet about the study  
 
 
 
 
PREPARE for Radical Cystectomy study  
Participant Information Sheet 
Version 5   09/05/2012   
 
We invite you to take part in a study we are running for patients who are due to 
have surgery for bladder cancer. Before you decide whether to enrol for the 
study we would like you to understand why the research is being done and what 
it would involve for you. One of our team members will go through the 
information sheet with you and answer any questions you have. We would  
suggest that you should take at least 15 minutes to read the information leaflet, 
and talk to others about the study if you wish.  
 
What is the purpose of the study? 
PREPARE  is a study that is being run jointly by the urology team at Norfolk 
and Norwich University Hospital and the University of East Anglia to look at the 
role of exercise before surgery in improving recovery after your operation. It is 
known that the human body will deal with physical stress better if it is 
“preconditioned” or trained. Athletes will train before major events. Surgery, 
such as that for bladder cancer is a stress on the body and we believe that your 
body may recover better if it is trained beforehand using regular simple 
exercises. 
 
Why have I been invited? 
You will shortly be having major surgery for bladder cancer and as such can 
take part in our study.  
 
Do I have to take part? 
It is up to you whether to take part. We will describe the study and go through 
this information sheet with you.  If you wish to take part, we will then ask you to 
sign a form. You are free to withdraw at any time, without giving a reason. This 
would not affect the standard of care you receive. 
 
What will happen to me if I take part? 
If you decide to enrol, one of our study doctors will take you through the consent 
form and ask you to sign. There is a planned gap of about four weeks between 
the decision to offer you surgery and the date of your operation. This time 
window allows you take part in the study with no added delay to your treatment. 
You may be having chemotherapy for a few months before surgery, and it is 
usual to wait 6 weeks after this before your surgery. If this is the case for you, 
we will use that time to allow you to take part in the study.  
The study involves regular sessions of supervised simple exercises that you 
will do at the lab at the University of East Anglia. You would be asked to attend  
twice a week, at convenient times for you, for  four weeks, during working hours. 
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Each session would last about an hour. We will also give you some simple 
exercises to do at home (such as brisk walking or cycling) for about half an hour 
at least once a week. 
 
The exercise plan will be tailored to your own ability, so if you are more fit you 
would do more heavy exercise than those who are less fit. 
 
We will take some measurements before and after the four weeks of the  study 
to see if your fitness is better. We will also see if your recovery is quicker or less 
complicated  than for others who have not done any exercise before their 
surgery. 
 
We would also need you to fill up certain questionnaires regarding your general 
wellbeing at different points during the study. This questionnaire called the 
FACT-Bl questionnaire has been used in previous studies (prevalidated) in 
patients with bladder cancer .This should not take more than 5 minutes to fill up 
and one of our team members would be happy to go through this with you. 
 
We are evaluating our treatment in a trial comparing this to standard care. 
Sometimes because we do not know which way of treating patients is best, we 
need to make comparisons.  People will be put into groups and then compared.  
The groups are selected by a computer which has no information about 
you – i.e. by chance.  Patients in each group then have a different treatment 
and these are compared. 
If you are interested in taking part you will receive either the new treatment (i.e 
exercise before surgery) or standard current treatment (which does not involve 
any exercise) to see which is best.    
 
You may also be invited to participate in group discussion sessions with other 
participants .These meetings called “focus group meetings”  are there for us to 
gauge the  feedback and experience of participants during the study.Each focus 
group session lasts between 30 to 45 minutes. 
 
 
 
Will I be paid any expenses ? 
The study is voluntary and as such you will not be for taking part, but we will 
reimburse you for travel costs due to your visits. 
 
What will I have to do? 
You will be asked to attend the lab at the University of East Anglia in Norwich 
twice a week to do the exercises and have measurements. These sessions will 
last about an hour. You will also be given an exercise plan to follow three times 
a week at home. We will supply you with a pedometer, a small instrument that 
will measure amount of exercise you have undertaken at home. 
However if you are in the group that receives standard care you will not need 
to attend these exercise sessions. 
 
What are the possible disadvantages and risks of taking part? 
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The exercise plan that you would do would only be based on your own fitness, 
and as such health risks such as heart problems or breathing difficulty are low 
(less than 1 in 10,000 episodes). All your exercise sessions in the lab will be 
supervised by a doctor. If you have any problems during these exercises we 
would advise you to stop and take necessary steps.During your participation in 
the study you would be covered by NHS  and university of East Anglia ( UEA) 
indemnity and insurance .The details of the cover is available on request. 
 
 
What are the possible benefits of taking part? 
We hope that this short period of exercise may make you more fit and cope 
better with the stress of surgery. Your recovery after surgery may be more 
smooth. If the results of the study show that that is indeed the case then it is 
expected that all patients who would be undergoing major surgery would be 
asked to go through a period of preoperative exercise training to enhance their 
recovery after surgery. 
 
What happens when the research study stops ? 
At the end of the study we will tell you how much improvement there has been 
in your physical fitness. If you wish after your surgery you may decide to 
continue on these simple exercise protocols to stay active and fit. 
 
What if there is a problem? 
If you're unhappy about any part of the study you should discuss it at the first 
instance with the principal investigator Mr S Banerjee. Should this fail to resolve 
the issues you can speak to the supervising consultants Mr M Rochester , Mr 
R Mills or Prof John Saxton.  
 
You can also take up the issues with the Patient Assistance and Liaison 
Services (PALS) in the Norfolk and Norwich University Hospital. 
 
Will my taking part in the study be kept confidential ? 
All the details about you will be kept confidential and will only be accessible by 
the research team. Your GP and your consultant would be kept updated of the 
fact that you are taking part in our study. It is very likely that the results of the 
study will be published or presented in the future however the data will be 
anonymised so that your confidentiality is not breached. 
 
What will happen if I don’t want to carry on with the study? 
Participation for the study is completely voluntary and as such you may 
withdraw from the study at any point without the need to give a reason. This will 
not affect your routine care or any care that you would receive before, during 
or after your hospital stay. The data that we may have collected till that point 
may however still be used with .If you loose the ability to consent after you have 
been recruited into the study, you would be  removed from the study but any 
data collected upto that point may still be used. 
 
Participation for the focus group meetings are also voluntary.You may decide 
to participate in the trial but not for the focus group meeting. 
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Who is organising and funding the research? 
The research is being jointly carried out by the urology department and the 
University of East Anglia.. 
 
Who has reviewed the study? 
The study protocol is being reviewed by the research and development 
department at the Norfolk and Norwich University Hospital and ethics approval 
has been sought from the Norfolk Regional Ethics Committee. 
 
 
Further information and contact details 
Mr S Banerjee 
Urology Department 
Norfolk and Norwich University Hospital 
Norwich 
NR4 7UY 
01603 286286, pager 1079 
 
